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Abstract 
Catalysis plays an important part in our society. Numerous transition metal catalysts have been 
developed which can convert many different substrates in a wide range of reactions. Catalysis 
also plays an important role in nature and therefore special catalysts, enzymes, have evolved over 
time. Enzymes are tremendously efficient giving high yields and selectivities both regio and 
chemical but have a limited substrate and reaction scope. It was speculated that by combining the 
two, an ideal catalyst can be obtained. We planned to achieve this by introducing a transition 
metal, the catalytic centre, into the chiral environment of a double helical oligonucleotide. The 
transition metals were introduced by coordinating them to a ligand which was located in the 
chiral environment of a double helix. The ligand was either covalently bound (Chapter 2) or non-
covalently bound (Chapter 3) to the oligonucleotide (Figure 1). 
 
Figure 1: A) covalent introduction of a transition metal into a nucleotide B) non-covalent introduction of a transition metal 
into a nucleotide 
For the covalent approach a phosphine ligand was chosen. A nucleoside was modified with an 
alkyne to which a phosphine moiety could be coupled via the copper catalysed 1,3-dipolar 
cycloaddition. The modified nucleoside was incorporated into an oligonucleotide before 
attempting to attach the phosphine moiety. The monomer was used as a ligand in allylic 
substitution and hydroformylation.  
In the non-covalent approach polyamide minor groove binders were functionalised with an 
amine linker. Phosphine moieties were connected via amide bond formation. Although the 
coupling worked effortlessly the phosphines oxidised during purification therefore dienes were 
also investigated.  
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Chapter 1: Introduction 
1.1: Increased environmental awareness 
At the moment Earth is the only planet we have found that supports complex life forms. In 
2007 Bounama et al.
1
 developed a model to predict the number of Earth-like planets in the 
Milky Way, in other words planets that can support life. From these predictions they 
concluded that the closest planet that can sustain primitive life (micro-organisms) is 30 light 
years (lyrs) away and for more complex life-forms we would need to look 130 to 200 lyrs 
away. So regardless if you believe climate change/global warming is caused by mankind,
2
 
that it is a natural occurrence
3
 or that it is all blown out of proportion,
4
 we have to take care 
of our world.  
Over the last half a century environmental awareness has been growing, this has led to a 
demand for cleaner production methods. Although it is difficult to quantify the effect that 
production processes have on the environment a number of people have attempted to do so. 
Sheldon
5
 proposed the term environmental factor, also known as the E-factor, as a tool for 
assessing the impact of a manufacturing process on the environment. The E-factor takes into 
account all the raw materials (excluding water) used during the manufacturing process of a 
product, including fuel, although this is often difficult to quantify. The E-factor is defined as 
the mass ratio of waste to product
5
 (Equation 1). 
Equation 1     
This means that the larger the E-factor the higher the environmental impact of a process is. In 
an ideal scenario all of the raw materials are converted into the product and therefore the E-
factor should be 0. In 2007 Table 1 was published showing the E-factors associated with 
different sectors of the chemical industry.
5
 
Table 1: E-factors in different sectors of the chemical industry 
Industrial sector E-factor Product tonnage 
Bulk chemicals 1 – 5 10
4
 – 106 
Fine chemicals 5 -50 10
2
 - 10
4 
Pharmaceuticals 25 -100 10 - 10
3
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In 1991 Trost
6
 introduced the term atom economy (Equation 2) after noticing that only a 
portion of the atoms of the starting materials were incorporated into the product in the 
methylation reaction utilising methyltriphenylphosphonium bromide (Figure 1). 
 
Figure 1: Methyltriphenylphosphonium bromide 
In this model the molecular weight (Mw) of the product was compared to that of the 
reactants. Atom economy has been well received by the scientific community and has been 
incorporated into the 12 principles of green chemistry.
7
  
Equation 2
8
            
Something that these and other proposals have in common is that they do not take into 
account the toxicity of the reagents used and waste produced. Hudlicky
9
 attempted to take the 
toxicity of the utilised reagents into account when he proposed the effective mass yield. The 
effective mass yield is defined as the mass of the desired product divided by all the utilised 
non-benign reagents (Equation 3). In contrast to Sheldon’s E-factor solvents and by-products, 
such as low concentration saline solutions, dilute ethanol and autoclaved whole cells with no 
known environmental impact, are not included in the equation. 
Equation 3
8
       
Sheldon also tried to take the toxicity of reagents into account by multiplying an 
environmental quotation(Q) with his E-factor giving an EQ-factor.
5
 The Q in this equation is 
an arbitrary value and takes into account the amount of a particular substance, its toxicity and 
the ease of recycling. 
It is very difficult to get an unambiguous value of environmental impact of a manufacturing 
process as among other things it is dependent on the process used, the ease of recycling and 
the amount of waste produced. Also there is limited information available on the 
environmental impact a substance has. However these equations (E(Q)-factor, atom economy 
and effective mass yield) as well has others give a good indication on the cleanness of a 
process.  
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All this focus on the environment led Anastas and Warner
10
 to coin the term Green Chemistry 
and define 12 principles associated with it.
7
 These principles can be summarised in four 
points.  
1) Waste prevention by utilising real-time analysis, efficient catalysts and choosing 
reactions with a high atom economy and low energy requirements.  
2) Minimise the effects of accidents such as release of toxic gas, explosions, fires and 
spillage by employing benign/less harmful chemicals. 
3) Use of renewable feed stocks. 
4) Design products that break down in benign degradation products that do not remain in 
the environment after they have fulfilled their purpose. 
Before the early 1990’s governments endeavoured to motivate companies to reduce waste by 
increasing the costs associated with waste disposal. This led to the closure of certain plants. 
The most famous of these was the phloroglucinol plant at OceAndeno (part of the DSM 
concern) which closed its doors in the early 1980’s.5 The production process of 
phloroglucinol (4, Scheme 1) began with the oxidation of 2,4,6-trinitrotoluene (TNT, (1)) 
with potassium dichromate in sulphuric acid, this was followed by a reduction using iron and 
hydrochloric acid.
5
 During this process a large amount of solid waste was produced e.g. 
Cr2(SO4)3, NH4Cl, FeCl2 and KHSO4 giving the plant an E-factor of about 40, which was 
high for a bulk chemical, and that combined with the increased costs of waste disposal made 
the process economically unfeasible.  
 
Scheme 1: Synthesis of phloroglucinol (4) from TNT (1) 
There are a number of possibilities that can be employed in order to reduce the amount of 
waste produced during a production process, these include changing the reactants and 
reagents and changing the reaction pathway. The last option can be achieved with the help of 
catalysts. 
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1.2 Advantage of using catalysis 
Catalysts are responsible for increasing reaction rates and allowing reactions to take place 
under milder conditions. Consequently they play a key role in the production of bulk 
chemicals.
11
 More than 90% of all products synthesised in the chemical industry have been 
obtained with at least one catalytic step and a prime example of this is the production of 
ammonia. By applying a high temperature and pressure to a vessel containing nitrogen and 
hydrogen nothing will happen despite the favourable chemical equilibrium.
12
 However if iron 
is added to the mixture then ammonia is readily formed. In fact over 140 million tons of 
ammonia are generated like this each year.
13
 
 
Figure 2: Catalysis energy diagram 
Utilising catalysts has another benefit which the fine chemicals and pharmaceutical industries 
are keen to exploit.
11
 Catalysts work by lowering the activation energy barrier of a specific 
route thus allowing the reaction pathway to change and thus changing product distribution 
(Figure 2). As a consequence selectivity can be tailored by choosing the right catalyst. For 
example in Figure 2 when no catalyst was used product A was the favoured product, however 
when a catalyst was used product B was the more favourable option.  
In chemical reactions different types of selectivity can be distinguished. The four types are 
listed below.
11
 
1) Chemoselectivity  => Selective targeting of one functional group in the presence of 
multiple functional groups 
2) Regioselectivity => Selective targeting of one functional group when it appears 
several times in the molecule 
3) Enantioselectivity => Selective formation of one enantiomer  
4) Diastereoselectivity => Selective formation of one diastereomer 
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1.2.1 Enantioselective catalysis 
Organic compounds with one chiral centre (enantiomers) or multiple chiral centres 
(diastereomers) usually have at least two non-superimposable structures. In a chiral 
environment these structures interact differently so that the observed outcome differs. Most 
biologically active compounds are chiral; therefore enantiomers and diastereomers are of 
special interest to the pharmaceutical industry. The difference in activity can be innocent such 
as producing a different taste, as in the case of asparagine, or devastating, as in the case of 
penicillamine where one enantiomer is anti-arthritic and the other is toxic
14
 (Figure 3). The 
differences are not necessarily this extreme and could simply be a difference in potency.  
Despite the importance of enantiomeric purity in the year 2000 only 40% of all drug sales 
were of enantiopure compounds.
15
  
 
Figure 3: Effect of different enantiomers 
In the past, industry often depended on a biochemical route when enantiopure products were 
required even though the reaction mixtures obtained were often dilute and required 
cumbersome separations. Efficient chemical routes were also available but these yielded the 
racemic mixture and thus needed to be resolved.
16
 One way to circumvent this problem was 
to synthesise the product with the aid of an asymmetric catalyst. Knowles was one of the first 
people to pioneer this approach and his ground breaking discoveries contributed to him 
receiving the Nobel Prize in 2001.
17
 
In the mid-twentieth century it was discovered that L-3,4-dihydroxyphenylalanine (L-Dopa) 
functioned as a potent anti-Parkinson’s disease drug. The required doses were high and this 
created a large demand for the rare amino acid.
18
 Monsanto was one of the companies to take 
advantage of this and started synthesising the drug starting from vanillin (5) (Scheme 2). The 
method involved utilising the Erlenmeyer-Plöchl azlactone synthesis before Hoffman-
LaRoche resolved and deprotected the product.
16-18
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Scheme 2: L-Dopa synthesis via the Erlenmeyer-Plӧchl azlactone synthesis 
A breakthrough came when Knowles used a phosphine based ligand (Figure 4, 11) to 
facilitate the rhodium catalysed asymmetric hydrogenation of intermediate 8 (Scheme 2). The 
product (9a, Scheme 2) was obtained with a modest enantiomeric excess (ee) of around the 
30%.
16
 Although the value was not high enough to be used industrially it showed that 
asymmetric catalytic hydrogenations employing a metal-ligand system were possible. After 
only a few optimisation attempts CAMP (cyclohexyl (2-methoxyphenyl)(methyl)phosphine, 
12) was developed and within 6 months of optimising incorporated into a 50 gallon 
production process. By employing an asymmetric catalyst the process was shortened and the 
amount of waste was reduced.
16, 18
 
 
Figure 4: Development of ligands used in the hydrogenation of L Dopa 
 
Since this discovery the field of asymmetric catalysis has expanded exponentially leading to a 
multitude of types of catalysts. 
1.3 Types of Catalysts 
The term catalysis was first coined by Berzelius in 1836
11, 13
 but mankind has been using 
catalysis longer than that. Initially catalysis was subdivided into two subgroups dependent on 
the phase in which the catalyst resided compared to the substrate, heterogeneous or 
homogeneous. In the case of heterogeneous catalysis the catalyst was in a different phase 
than the reaction mixture. For example the reactants can be present in a solution or as a gas 
which is then passed over the solid catalyst. This had the advantage that the reaction mixture 
was easily separated from the catalyst. In the case of homogeneous catalysis the catalyst and 
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the substrate both reside in the same phase, typically but not exclusively in solution. A classic 
example of homogeneous catalysis was the catalysed hydrolysis of starch by acids which 
Kirchhoff first noticed in 1814.
13
 
This subdivision has become outdated with the invention and expansion of different types of 
catalysis. Currently there are four main types of catalysis namely heterogeneous, 
organometallic catalysis also known as homogeneous catalysis, organocatalysis and 
biocatalysis. The rest of this chapter will focus on homogeneous catalysis and biocatalysis. 
Man-made catalysts and natural catalysts each have their own advantages and disadvantages 
and therefore a new field has emerged combining these two,
19
 this will also be highlighted. 
Ideally a catalyst transforms one functional group in the presence of several, sometimes more 
reactive groups. The reaction must also be highly atom efficient and take place under mild 
conditions as dictated by green chemistry.
10
 In the case of asymmetric catalysis the catalyst is 
responsible for subtle effects that enable the formation of one enantio/diastereomer over the 
other. The difference between the formation of enantiomers is very small as energy 
calculations revealed that there is only a 3 kcal (12.6 kJ) difference in transition states 
required to form the different enantiomers.
18
 Although the differences are small specific 
enantiomers can be targeted, enzymes are especially accomplished in this. 
1.4 Organometallic catalysis 
The first organometallic catalysts used in industry were used for high volume production of 
chemical intermediates and polymers. Nowadays organometallic catalysts are also used for 
more complex compounds such as pharmaceuticals, flavours, fragrances and agrochemicals. 
They are especially good in carbonylation reactions, C-C coupling and enantioselective 
catalysis.
20
 
Although homogeneous catalysts existed before Wilkinson discovered that chloro-
tris(triphenylphosphane) rhodium ([RhCl(PPh3)3]) was an effective catalyst in hydrogenation 
reactions with unhindered olefins, this was the first time that the reaction rates rivalled those 
of heterogeneous catalysis.
18
 
Metal complexes containing chiral ligands are currently the most used asymmetric catalysts. 
The chiral ligands were needed to direct the reactivity and selectivity of the metal centre. A 
lot of work has been done to further understand the mechanism of catalytic reactions giving a 
better understanding of the requirements of a ligand. In other words a ligand can potentially 
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be designed rationally. Unfortunately due to the complexity of these reactions the 
development is still largely dependent on trial and error.
21
 
 
Figure 5: Examples of privileged ligands.
22
 
In most cases the chiral moieties (the ligands) were covalently attached to the active site (the 
metal centre) to facilitate the transfer of chiral information.
23
 In organometallic catalysis 
these enantiopure ligands were very diverse. This diversity was not limited to the ligand 
structure and metal centre but also to the type of reaction which is catalysed. Some of these 
catalysts can achieve high ee’s over a range of reactions and are denoted as “privileged 
ligands” (Figure 5).22 
1.5 Enzymes 
1.5.1 Natural enzymes 
Enzymes are proteins, often containing a reactive cofactor, which can catalyse chemical 
reactions.
24
 Enzymes have evolved over millennia and therefore, it is not surprising that they 
are highly efficient and selective catalysts.  
 
Figure 6: Schematic representation of the action of an enzyme   
The active site is often buried deep inside the enzyme surrounded by the side chains of the 
amino acids that are in the vicinity. It is believed that the substrate is extracted from the 
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aqueous media and forms a complex with the enzyme (ES) in the active site. Once the 
reaction is complete the product is released freeing the active site for another cycle.
25
 It is 
believed that the substrate is held in place via various noncovalent interactions such as 
hydrogen bonding, Van de Waals interactions, sulfur bridges and hydrophobic interactions.
24
 
Proteins consist of amino acids which are connected to each other via stable amide bonds. 
These bonds have a partial double bond character (Figure 7) which reduces the flexibility and 
together with hydrogen bonding, disulfide bonds and hydrophobic effects help form the 3-
dimensional structures that are required for biological activity. Proteins however are not rigid 
and can change their shape to bind substrates. This ability to change shape is caused by the 
free rotation around the C-Ccarboxyl bond which are single bonds (Figure 7).
26
 
 
Figure 7: Coupled amino acids 
Among the theories that exist to explain the mechanism of how an enzyme works the 
following two are most widely accepted. The first dates back to 1894 when Emil Fischer 
developed the “lock and key” model to explain how an enzyme works. Fisher speculated that 
the substrate (key) had to fit into the enzyme (lock). This would explain both the excellent 
enantioselectivity and substrate specificity.
25
 However in Fisher’s model the enzyme was 
rigid and we now know that this is not the case.
14
 
More recently (late 1960’s) Koshland revised this mechanism, giving rise to the induced fit 
theory (Figure 6). This theory assumes that a substrate binds to an active site and once bound 
the enzyme can wrap itself around the substrate thus changing the properties of the active 
site. However not all the substrates, which bind to the active site, induce a reaction. The most 
likely reason for this is that the active site is unable to rearrange itself into the required form. 
Proteins are remarkable catalysts having many attractive features like providing high chemo-, 
regio- and stereoselectivities in reactions containing substrates with multiple functional 
groups and achieving this with exceptional turnover frequencies (TOF). This selectivity 
means that by employing enzymes lengthy procedures with protecting and deprotecting 
sequences of functional groups can potentially be avoided.  
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The benefits of using enzymes to catalyse chemical reactions has not been lost on chemists as 
they have been employing enzymes in organic chemistry for over one hundred years 
including several industrial applications.
27
 
1.5.2Artificial metalloproteins 
A great deal of effort has been applied to the manufacture of artificial metalloproteins for the 
purpose of catalysis and biomedicines as well as O2 storage (Table 2).
28
 As mentioned earlier 
enzymes are very efficient catalysts but unfortunately cannot assist in all the conversions that 
are beneficial in today’s society. To enable enzymes to catalyse these reactions a substantial 
amount of work has been put into enzyme modification and transition metals have been 
introduced into the chiral environment of proteins. This is relatively new approach because in 
the past it was difficult and expensive to synthesise the desired protein. This field has seen an 
exponential growth due to developments made in protein manufacturing such as the 
development of cloning techniques, site-directed mutagenesis, protein expression and 
polymerase chain reactions (PCR).
19
 
Table 2: Overview of proteins and metal complexes for the preparation of artificial metalloproteins and their functions 
Protein Metal complex Function 
Myoglobin Heme derivatives O2 storage/Electron transfer 
 Cr and Mn Schiff base complexes Catalyst 
(Strept)avidin Biotinated Rh and Ru complexes Catalyst
29
 
Albumin Hume, Cu and Rh complexes Catalyst/O2+ storage 
Lysozyme Ru and Cu complexes Metal drug 
Kinase Ru complex Inhibitor 
Virus Au, CoPt and FePt clusters Material 
 
One of the first studies on artificial metalloenzymes was done in the late 1970s. By 
embedding an achiral homogeneous catalyst within a protein, Whitesides and Wilson
30
 
pioneered the concept of artificial metalloenzymes and created a hybrid catalyst. Avidin was 
chosen as the protein because of its characterised structure and ability to bind tightly to 
biotin. Biotin was functionalised with a bidentate phosphine moiety (Biot-1, Scheme 3) and 
the tight binding ensures that the catalytic site does not migrate. When avidin-Biot-1 complex 
was coordinated to a rhodium species and used in the hydrogenation of α-acetamidoacrylic 
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acid, a modest ee of 44% was achieved. The observed ee was attributed to avidin as no 
noticeable ee was observed when only the Biot-1 rhodium complex was used. 
 
Scheme 3: Biotin modified with a bidentate phosphine 
The modest ee that Whitesides obtained with avidin led Ward et al.
29
 to question the affinity 
that the Biot-1 rhodium complex had for avidin. They reasoned that at neutral pH avidin 
would have a cationic character (Isoelectric point (pI) = 10.4) and therefore the cationic 
rhodium complex would be forced away by coulomb repulsion. Therefore they opted to use 
streptavidin which like avidin readily binds to biotin (Ka ca. 10
14
 M
-1
) but has a pI of 6.2. The 
deeper binding pocket of streptavidin, compared to avidin, could also have a beneficial effect. 
Table 3: Results from Ward et al. on hydrogenation of α-acetamidoacrylic acid using a metalloenzyme 
Entry Ligand Host protein Buffer ee (%) 
1 Biot-1 Avidin Phosphate 37 (S) 
2 Biot-2 Avidin MOPS
a 
0 
3 Biot-1 Streptavidin Acetate 92 (R) 
4 Biot-2 Streptavidin Acetate 20 (S) 
5 Biot-3 Avidin MOPS 60 (S) 
6 Biot-3 Streptavidin Acetate 24 (S) 
       a
4-Morpholinepropanesulfonic acid 
Their results are depicted in Table 3. When avidin was used as the host protein in 
combination with biotinylated amino-diphosphine ligands Biot-1and Biot-2 low enantiomeric 
excesses were obtained (entries 1 and 2). By changing the protein to streptavidin higher 
enantiomeric excesses were attained (compare entries 1 with 3 and 2 with 4). Both the active 
site of the protein and the phosphine ligand can be modified to improve the ee, providing the 
association constant remains high.
29
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1.6 Oligonucleotides as catalysts 
1.6.1 Unmodified nucleic acids 
Enzymes are not the only catalysts that nature employs. It is believed that before enzymes 
evolved, ribonucleic acids (RNAs) were the catalyst of choice. This led to the development of 
the “RNA world” theory. This hypothesis started taking shape back in 1968 by Crick31 and 
Orgel
32
 but the term was not introduced until 1986 when Gilbert
33
 used it for the first time. 
This theory was further strengthened when RNA molecules with catalytic properties were 
discovered. One example of the catalytic activity of RNA is ribosomal RNA (rRNA) which 
catalyses and regulates protein synthesis.
34
 
It is truly remarkable that with just 4 different chemical subunits RNA has a multitude of 
functional structures. This potential of forming different structures can be very beneficial for 
catalysis.
35
 It is conceivable that RNA achieves its selectivity by using the induced fit 
mechanism.
36
 Mono-valent metal-ions such as sodium (Na
+
) and potassium (K
+
) primarily 
affect the secondary structure while divalent ions like magnesium (Mg
2+
) and calcium (Ca
2+
) 
have a profound effect on the tertiary structure of RNA. With the help of these ions RNA can 
adopt structures akin to those of a protein (Figure 8).
34
 Besides helping the folding of RNA 
metal ions help to stabilise the molecule.
37
 
 
Figure 8: Structure of a protein (left) and RNA molecule (right) of similar size
34
 
 
Over time nature made the transition from a purely “RNA world” to a “RNA-DNA-protein 
world”. It is assumed that nature evolved from using RNA to store genetic data to DNA 
(deoxyribonucleic acid), because of the chemical stability of the DNA backbone.
38
 RNA and 
DNA are both nucleic acids which use nucleotides as building blocks. These nucleotides 
consist of a furanose sugar moiety and one of five bases. These subunits are held together via 
phosphodiester bridges to form a strand (Figure 9).
24
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Figure 9: Nucleotides found in RNA and DNA. 
 
The bases are derivatives of either pyrimidine or purine. The most common of these are 
cytosine (C), thymine (T), uracil (U), adenine (A) and guanine (G) (Figure 9). Cytosine, 
adenine and guanine can be found in both DNA and RNA. However thymine is primarily 
found in DNA while uracil is found in RNA. To distinguish between DNA and RNA strands 
a lowercase letter “d” which denotes deoxy, precedes  the abbreviation of the base in DNA.26 
The most substantial difference between RNA and DNA can be attributed to the furanose 
sugar moiety. In RNA the sugar moiety has three hydroxyl groups and is known as a ribose 
group while DNA has only two hence the name deoxyribose (Figure 10).
26
 The extra 
hydroxyl group in RNA is also a reason why RNA is less stable than DNA. This 2’-hydroxyl 
group makes the phosphodiester linkage more prone to nucleophilic cleavage. 
O
HO B
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HO B
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Figure 10: The sugar moieties found in DNA and RNA 
 
In the late 1940’s Chargaff discovered that the bases found in RNA and DNA form unique 
pairs. Cytosine and guanine bind to each other via three hydrogen bonds and adenine and 
thymine/uracil form the other pair and are held together via two hydrogen bonds (Figure 11). 
This is known as Chargaff’s rules and more commonly as Watson and Crick base pairs.26 
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Figure 11: H-bonding between base pairs 
 
Watson and Crick took advantage of Chargaff’s findings and in 1953 concluded that DNA 
was a complementary double helix.
26
 Two polynucleotide strands run in opposite direction 
and coil upwards from left to right to form a right handed helix. In the helix the polar sugar 
phosphate backbone is on the outside and the hydrophobic bases are stacked on the inside 
(Figure 12). Generally base pairing is perpendicular to the helix central axis. The helix is 
further stabilised via - stacking of the bases on the same strand. The helix also forms two 
observable grooves namely a major and a minor.
24,26 
A complete rotation of the double helix 
requires 10-10.5 bases and has a diameter of about 20 Å. The stacked bases are separated by 
3.4 Å.
39
 The DNA double helix described above is known as the B-DNA and is the most 
common double helix found in nature. DNA is very dynamic and other helices are also 
obtainable, the most renowned of these are known as A- and Z-DNA (Figure 12). 
A-DNA is known as the dehydrated form and is found when the humidity is below 75 % so 
less water binds to the phosphate backbone. Like B-DNA it is a right handed double helix 
and contains a major and a minor groove, however it is shorter and wider and the bases are 
tilted about 19
o
 out of plane. This structure is not confined to DNA, as RNA hairpins and 
RNA-DNA hybrids also adopt this form.
26
 
 
Figure 12: Three crystal structures of DNA from left to right A (5’-d(CCGGCC)-3’
40
, B (5’-d(CGC GAA TTC GCG)-3’
41
and Z (5’ 
d( CGC G)-3’
42
 
Z-DNA was first resolved by Rich et al.
43
 in 1979 and has different properties than both A- 
and B-DNA. Most noticeable is that the double helix is left handed. Unlike the other two 
forms only one deep helical groove. Z-DNA consists of short strands composed primarily of 
C and G bases.
26
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Double stranded DNA is the most abundant form of DNA although triple stranded DNA also 
exists. Early results showed that triple stranded DNA can form wherever there is a continuous 
sequence of purine bases in the DNA strand. Triple stranded DNA can obtain the A-form and 
consists of 11 to 12 bases per turn.
44
 When there is a high concentration of G bases 
quadruplexes can form which are known as G4 structures. These structures are planar 
assemblies of four guanines bound together via Hoogsteen base pairing (Figure 13). The 
guanine bases can be located on one strand or multiple strands.
45
 
 
Figure 13:  G-quadruplex structure held together via Hoogsteen hydrogen bonding. 
Understanding how DNA helices are formed has facilitated the synthesis of 2- and 3- 
dimensional structures. DNA makes an ideal scaffold to build supra-molecular structures.
46
 
The formation of base pairs is energetically favourable and therefore DNA helices are formed 
so that the maximum number of bases are paired.  
DNA nanotechnology generally utilises branched DNA structures containing junctions. One 
of simplest branched structures that can be envisioned is a four-arm junction which can be 
formed using four separate single strands of DNA. These strands are partially complementary 
to each other and contain single stranded end parts known as sticky ends (Figure 14). 
 
Figure 14: DNA superstructures containing sticky ends
47
 
These junctions can be used as the backbone for constructing polygonal and polyhedral stick 
figure devices. The “sticks” or lines signify the double helix DNA, while the branches are the 
junctions where the helices come together.
48
 For 30 years the sticky-ended cohesion has been 
used in genetic engineering for directing the assembly of DNA molecules.
47a
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Rothemund
49
 has made 2-dimensional structures of DNA (see Figure 15). The scaffold is 
held in place by over 200 short oligonucleotides the so-called “staple strands”. These short 
double helices are placed parallel to each other within the scaffold and are held in place by a 
periodic collection of crossovers. This is than filled with a long single DNA strand of about 
900 nucleotides which is folded back and forth. The resulting structure has a spatial 
resolution of 6 nm and is roughly 100 nm in diameter. Complex patterns have been 
synthesised using this method. 
 
Figure 15: Left the model, right the experimental result using Rothemund’s method
50
 
1.6.1.1 The effect of metals on DNA helices 
Like with RNA molecules metal ions have a profound effect on the stability and binding 
properties of DNA. Riggs et al.
51
 demonstrated this back in the early 1970’s by comparing 
the binding constant of DNA with a lac repressor protein in 0.01 M MgCl2 and either 0.01 M 
or 0.18 M of KCl. The binding constant decreased by two orders of magnitude when the 
concentration of the KCl solution was increased from 0.01 M to 0.18 M.  The binding 
constant was further decreased by excluding MgCl2.
52
 Lyons and Kotin,
53
 Bauer
54
 and Ott et 
al.
55
 observed that low concentrations of magnesium had a stabilising effect on the helices, 
but high concentration tended to lower the helix coil melting temperatures. High 
concentrations of transition metals also have a destabilising effect on the DNA helix causing 
base pair dissociation at lower temperatures than with mono-valent alkali metal ions or 
divalent alkaline earth ions.
56
 
1.6.2 Aptamers 
Oligonucleotides which bind effectively to a wide range of molecules are called aptamers.
57
 
Aptamer comes from the Latin word aptus meaning to fit and it is used for DNA and RNA 
molecules that specifically bind to target molecules from proteins to small organic and 
inorganic molecules. Aptamers are generally short oligonucleotides consisting of about 30 to 
a few hundred nucleotides. Smaller aptamers do exist as Anderson and Mecozzi
58
 showed 
with their 13 nucleotide aptamer that binds theophylline but they are rare. 
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Since the advent of Systematic Evolution of Ligands by EXponential enrichment (SELEX) 
by Tuerk et al.
59
 and Ellington et al.,
46
 in the 1990s it has been used to identify aptamers. A 
benefit of using oligonucleotide aptamers is that they can be rapidly synthesised using a DNA 
synthesiser.
60
 The great advantage of the SELEX method is that nucleotides that bind 
selectively to target molecules can be identified from large populations of random 
oligomers
57
 (Figure 16). SELEX is typically performed utilising oligomers that are longer 
than 20 bases in length
61
 and are flanked by defined 5’ and 3’ primer sequences that are 
generally 18-24 bases in length.
60
 
 
Figure 16: A schematic representation of SELEX 
In Figure 16 a schematic representation of SELEX is given. First a library of random single 
stranded oligonucleotides
57
 is synthesised via a DNA synthesiser using a mixture of 
nucleosides. This is then amplified using PCR. The affinity of DNA/RNA molecules for the 
substrate is investigated by loading the nucleic acids onto a column packed with immobilised 
target molecules. After washing away all the molecules that show no affinity to the targets, 
the bound DNA is removed by eluting the column with a solution containing target 
molecules. Using PCR the eluted strands are amplified again and the process is repeated. This 
is done several times until the percentage of nucleic acids that are washed away is small 
leaving behind only the DNA/RNA molecules that shows a high affinity for a target 
compound.
60
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1.6.3Artificial metallo nucleic acids 
 
Figure 17:  Left: the HPLC trace of the Diels-Alder reaction catalysed by D-RNA and a representation of D-RNA, Right: the 
HPLC trave of the Diels-Alder reaction catalysed by L-RNA and a representation of L-RNA. The light gray trace in the 
chromatogram corresponds to the uncatalysed background reaction.
62
 
In 2000 Jäschke et al.
63
 reported that a 49-mer D-RNA enzyme, a ribozyme composed of D-
nucleotides (Figure 17),  accelerated the bimolecular C-C bond formation between anthracene 
derivatives and small maleimides through a Diels-Alder reaction (Scheme 4). In the 
uncatalysed reaction the expected racemate was obtained however when the D-RNA enzyme 
was employed 90 % ee was obtained. This good enantioselectivity can be attributed to the 
fact that the RNA molecule is a homochiral molecule.  When the mirror image (a  synthetic 
49-mer composed of nucleotides with the L-configuration (L-RNA), Figure 17) was 
employed a similar reaction rate was observed and the opposite enantiomer was formed.
63
 
 
Scheme 4: Diels-Alder reaction catalysed by a RNA enzyme reported by Jäschke 
The increasing popularity of replacing organic solvents with water and the discovery of 
RNAzymes has fuelled the interest in using nucleic acids as catalysts. Two approaches can be 
envisioned for the introduction of transition metal complexes into the chiral environment of a 
DNA molecule. Firstly a metal-ligand complex can be introduced via a non-covalent 
approach with the help of intercalators or groove binders and secondly it can be covalently 
attached to the nucleotide (Figure 18).  
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Figure 18: Schematic representation of DNA-based asymmetric catalysis using the supramolecular (A) covalent (B) non-
covalent 
The difference between groove binders and intercalators is where they bind. In Figure 19 a 
schematic representation is shown depicting a groove binder (thick vertical line, A) in a 
double helix and an intercalator (horizontal think line) binding to a double helix (B). In 
principle groove binding substances fit into the minor or major groove without causing major 
changes to the helix. An intercalator on the other hand by definition stacks itself between 
successive base pairs,
64
 which does affect the double helix.  
 
Figure 19: A) Schematic representation of a groove binder (fat vertical line), B) Schematic representation of an 
intercalator (fat horizontal line) 
In 2005 Roelfes and Feringa
65
 reported an asymmetric Diels-Alder reaction catalysed by a 
DNA-based metal catalyst. Salmon testes DNA were used for this study. The catalyst 
complex was formed in situ by reacting Cu(II) with a ligand which consists of a DNA 
intercalator such as 9-aminoacridine, a spacer and a metal binding group (Scheme 5).  
A series of control experiments were carried out whereby one of the three elements of the 
catalyst was excluded in each reaction. The results indicated that DNA, a ligand and Cu(II) 
were needed to obtain ee. The ligand and the spacer length played a crucial role in obtaining 
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good enantiomeric excesses. With n = 1 (Scheme 5) an ee of 49% was obtained however 
when the chain length was increased to 5 carbons the ee was negligible. 
 
Scheme 5: DNA catalysed asymmetric Diels-Alder 
Roelfes et al.
66
 have since optimised this approach by removing the need for a spacer entirely 
(Figure 20). This was achieved by utilising achiral copper complexes based on bidentate 
ligands known to intercalate with DNA. As a result the reactive Cu(II) centre was brought in 
closer vicinity to the DNA double helix and as a result the ee increased dramatically from 
49% ee to 96 %.
66
  
 
Figure 20: First and second generation intercalators for DNA based catalysis 
In 2007 Roelfes et al.
67
 used their approach to catalyse Michael additions in water. Using 
Salmon testes DNA and a copper catalyst coordinated to L3 high enantiomeric excesses of up 
to 99% could be obtained (Scheme 6). These reactions could be performed on a preparative 
scale with the possibilty of recycling the catalyst. Friedel-Crafts alkylations were also carried 
out using this method generating enantiomeric excesses of up to 93 %.
68
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Scheme 6: The Michael addition using an artificial DNAzyme 
Originally their focus was on reactions that have successively been catalysed by 
organometallic complexes. In 2010 they reported a method for asymmetric conjugate addition 
of water to α,β-unsaturated ketones.69 Synthesising chiral β-hydroxy ketones, a structural 
building block for the synthesis of natural products, via the asymmetric conjugate addition of 
water to α,β-unsaturated ketones is problematic when using transition metal catalysts 
especially when the reactions take place in water. Hydratase enzymes can catalyse such 
transformation with high enantiomeric excesses however the substrate scope is limited. 
Similar to their other endeavours Roelfes et al.
69-70
 have employed salmon testes DNA along 
with a catalytically active Cu
2+
complex (Cu-L). Their model reaction was the hydration of 2-
acyl imidazole to form β-hydroxy ketone (Scheme 7). 
 
Scheme 7: The hydration of 2-acyl imidazole to form β-hydroxy ketone 
The minimum catalyst loading required was 3 mol% which corresponds to a ratio of Cu-
complex to DNA base pair of 1:6. Utilising the lower catalyst loading had an effect on both 
the conversion and the ee (Table 4). 
Although this research shows that metallo-DNA catalysis is possible there is a major problem 
with their approach. The ligands bind randomly to the double helix in multiple locations. 
Therefore, there are several different catalytic sites and it is difficult to determine which site 
is responsible for the observed selectivity and hence it cannot be easily optimised to improve 
its performance. 
 
Chapter 1: Introduction 
22 
Table 4: Hydration of 2-acyl imidazoles to for form β-hydroxy ketones 
Entry R
1 Reaction 
time (h) 
Ligand 
Conversion 
(%) 
ee (%) 
1 t-Bu 24 L2 55 72 (R) 
2 Me 7 L2 100 72 (R) 
3 i- Pr 7 L2 71 60 (R) 
4 Ph 24 L2 0 -- 
5 t-Bu 24 Cu(NO3)2 20 42 (S) 
 
The results of Roelfes and Feringa were impressive nevertheless some groups have opted to 
use the covalent approach. The greatest advantage of this approach is that it enables a certain 
amount of control in adapting the chiral environment of the transition metal. In this approach 
the nucleotide is modified to allow coordination of a transition metal. 
In 2010 Jäschke et al.
71
 modified a nucleotide with a diene functionality. This was 
subsequently coordinated to iridium and tested in allylic amination. Although the 
enantiomeric excesses were low (around 20 %) they did notice that the complementary strand 
had an effect on the observed ee. When single stranded DNA was used an ee of up to 24% 
was found on the other hand when double stranded DNA was used the ee was negligible. 
When RNA was used as the complementary strand the other enantiomer was obtained. 
Phosphines are more versatile ligands than dienes so ideally we would like to employ this 
functional group. Phosphine chemistry has been employed in other branches of DNA 
chemistry. Triphenylphosphine has been introduced into one DNA strand while the other 
strand holds a fluorescein-labelled probe containing an α-azido ether linker connected to a 
fluorescence quencher. When the two strands are mixed together the phosphine reacts with 
the azide and cleaves the linker thus liberating the fluorescence quencher and allowing 
fluorescence to be detected.
72
 The phosphine modified DNA strand was purified by HPLC. 
Mass spectrometry showed the presence of phosphine oxide which they presumed happened 
during purification;
73
 however this could also have happened during sample preparation for 
mass spectrography. 
In the method employed by our group
74
 we incorporate a modified nucleotide into a DNA 
strand which was subsequently coupled to a ligand containing a phosphine (Scheme 8). This 
nucleotide was then coordinated to a transition metal.  
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R
1
=R
2
= H (dppdU); R
1
=R
2
= Ac (AcdppdU); R
1
= deoxyadenosine-3-phosphate, R
2
= deoxythyidine-5-phosphate dinucleotide 
dAdppdUdT) 
Scheme 8: Synthesis of 5-diphenylphosphine-2’-deoxyuridine 
When the monodentate ligand dppdU, where dpp is diphenylphosphine, was used in 
palladium catalysed asymmetric allylic amination (Scheme 9) an ee of up to 82% was 
obtained. Like in previously mentioned reactions the solvent influenced the ee, when THF is 
used the absolute configuration was S while in DCM it was R. Unfortunately when 
trinucleotides dAdppdUdT and dCdppdUdG  were used the ee dropped. 
74
 
 
Scheme 9: Asymmetric allylic amination: addition of benzylamine to 1,3-diphenyl-2-propenyl acetate 
Recently we have managed to introduce a phosphine moiety onto a long DNA strand (15 
nucleotides) and coordinate [PdCl(η3-allyl)] to it.75 Caution had to be taken to avoid oxidation 
of the phosphine moiety although Jäschke et al.
76
 reported that their phosphine modified 
DNA was stable under HPLC conditions and two of the strands were sufficiently stable on 
storage in solution. This illustrates the importance of choosing the sequence of the 
nucleotides. 
The examples above show that both DNA and RNA are well-suited scaffolds for the 
development of  hybrid transition- metal catalyst There are however a number of reasons to 
focus on the use of DNA over RNA. Firstly DNA nucleotides cost considerably less than 
RNA nucleotides.
77
 This can be attributed to the protection of the 2’-OH of RNA during 
oligonucleotides synthesis. Secondly DNA is both chemically and biochemically more stable; 
furthermore DNA synthesis gives slightly better yields than RNA synthesis.  
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1.7 Project Aim and thesis outline 
As mentioned earlier waste production is a major concern in chemical industry and in 
particular in the fine chemical industry. In order to combat this waste production, effective 
catalysts need to be developed. These catalysts have to provide exceptional chemo-, regio- 
and enantioselectivities rivalling those found in nature, enzymes. Nature’s catalysts 
unfortunately cannot perform all the types of catalysis that play an important part in industry 
today. Mankind has therefore turned to transition metals to catalyse these reactions. 
Unfortunately, only a few existing transition-metal catalysts, rival the performance of 
enzymes. 
In recent years a new field has emerged whereby large bio-molecules are used in combination 
with transition metals. This field aims to combine the powerful molecular recognition 
properties of biomolecules with the catalytic power of transition metal catalysis, to create 
artificial metalloenzymes. The selected bio-molecule for this thesis was DNA. DNA is a 
homochiral molecule which can easily be modified and this is an enormous advantage when 
designing a catalyst. Furthermore ligands can be used to orientate the substrate in a 
favourable way, which enhances selectivity. Hydrogen bonding has been used as a tool to 
accomplish this.
78
 The nucleotide is in fact one large ligand which has the potential to form 
multiple hydrogen bonds and thus orientates the substrate. The DNA ligand can be optimised 
by altering the 3-dimensional structure of DNA. This can be done by varying the backbone 
length and composition of the base sequence. By carefully choosing the base sequence 
hairpins and loops can be generated thus changing the environment of the metal and thus 
influence the catalytic site (Figure 21).  
 
Figure 21: Hairpins and loops in DNA 
 
Two approaches can be envisioned to introduce a transition metal into the double helix. The 
metal moiety can either be covalently attached to a DNA strand or it can be non-covalently 
bound. Chapter 2 will focus on the first approach and Chapter 3 on the second. The choice of 
the ligand coordinating to the metal is vital. Phosphine moieties were selected because they 
are known to be effective ligands in homogeneous catalysis, especially in combination with 
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late transition metals for reactions such as hydrogenation and allylic substitution. Phosphines 
have an additional advantage that they coordinate more strongly to the late transition metals 
used in these reactions than nitrogen which is abundant in DNA, thus reducing the chances of 
creating multiple catalytic sites during catalysis. In Chapter 4 the following catalytic 
reactions with phosphine nucleotides as catalysts will be discussed: allylic substitution, 1,4-
dipolar cycloaddition and hydroformylation. 
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Chapter 2: Covalent approach 
2.1 Introduction 
As mentioned in Chapter 1, ligands coordinating to a transition metal can be introduced into 
the nucleic acid either non-covalently
1
 (Chapter 3) or covalently.
2
 This chapter will focus on 
the covalent approach. Using this approach the ligand can be introduced either via a pre-
synthesis (oligonucleotide is synthesised) or a post-synthesis (oligonucleotide is modified) 
protocol
3
 (Figure 1). Either way a non-natural oligonucleotide is formed containing a moiety 
with the desired functionality. In the pre-synthesis protocol a nucleotide is modified with a 
ligand and subsequently incorporated into an oligonucleotide either by enzymatic means or 
by chemical DNA synthesis. In post-modification a moiety is introduced to which a ligand 
can be attached after the oligonucleotide has been synthesised. 
 
Figure 1: 1) pre-synthetic incorporation of a ligand, 2) post-synthetic incorporation of a ligand 
Chemical synthesis of oligonucleotides can take place manually or using automated methods 
(employing a DNA synthesiser). The automated synthesis takes place on a solid support, 
often with the first base of the sequence already attached via the 3’hydroxyl group. A clear 
advantage of solid support synthesis is that large excesses of reactants can be used to increase 
the yield and subsequently washed away. The use of large excesses of reactants ensures that 
high conversions can be obtained, often approaching 100 %. 
In 1964 it was shown that a dipeptide could be synthesised on a styrene-divinylbenzene co-
polymer and subsequently removed. Letsinger and Mahadevan
4
 adopted this approach to 
synthesise oligonucleotides on a solid support. The phosphorylation was achieved by reacting 
a -cyanoethyl phosphate with the nucleoside on the styrene polymer. Short strands of 
oligonucleotides could effectively be synthesised on a large scale using this approach. This 
was later improved
5
 by using phosphites instead of phosphates to introduce the phosphate 
into the backbone. Beaucage and Caruthers
6
 further optimised the coupling by changing from 
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phosphorochloridites (ROPC12 or ROP(OR’)CI) to phosphoramidites. This simple change 
revolutionised DNA synthesis and is now widely used in (automated) DNA synthesis.  
The sugar moiety of a deoxy nucleoside contains two hydroxyl groups therefore one needs to 
be protected to avoid double phosphorylation when introducing the phosphoramidite. 
Fortunately the two hydroxyl groups have different reactivities. The 5’ hydroxyl group is a 
primary functionality and therefore more reactive. This group is first protected with a DMT-
group (4,4'-dimethoxytrityl). After this the 3’ hydroxyl group can be phosphorylated (Figure 
2). The advantage of using DMT as protecting-group is that upon removal a red DMT-cation 
is formed. This cation is used to quantitate the efficiency of the coupling either via UV 
spectroscopy or more regularly in automated synthesis by measuring the conductivity of the 
trityl cation in the waste mixture. 
 
Figure 2: Nucleoside functionalised for DNA synthesis 
The automated synthesis (Scheme 1) proceeds from 3’ to 5’ with the initial 3’ hydroxyl group 
attached to the solid support, and the 5’ hydroxyl group of the growing strand is protected 
with a DMT- group. This protecting group is removed by the addition of an acid (often TCA 
(trichloroacetic acid)). An activated phosphoramidite is added which subsequently reacts with 
the liberated hydroxyl group. Ideally the yield of this coupling is 100% but this is not always 
the case, especially in the past, therefore a capping agent, generally a mixture containing 
acetic anhydride, is added to cap the 5’ hydroxyl group. The capping prevents unreacted 
smaller chains from growing and thus simplifies purification. The final step in the synthesis is 
the oxidation of the phosphite group forming a phosphate. The oligonucleotide can then be 
removed from the solid support by heating it in the presence of a base, generally ammonia. 
This has the added advantage that the protecting groups are removed at the same time. The 
protecting groups which are used will be explained later on. 
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Scheme 1: Schematic representation of automated solid supported DNA synthesis 
The activation of the phosphoramidite usually takes place by reacting it with 1H-tetrazole, a 
weak acid. Once activated it becomes reactive and can react with other functionalities, such 
as the 5’ hydroxyl group on the previous nucleotide. To avoid unwanted side-reactions during 
the synthesis all reactive functionalities present on the nucleoside need to be protected. Apart 
from the hydroxyl group there are other reactive groups present in the nucleosides i.e. 
exocyclic amine groups. This amine group also has the potential to react with the activated 
phosphoramidite. Thymidine and uridine are the only natural occurring nucleotides that do 
not have a reactive functional group and thus do not require protecting groups on the base. 
Figure 3 shows some of the commercially available protected “natural nucleotides”.7   
 
Figure 3: Commerically available nucleotides with their protecting groups 
The protecting groups on the amines are simultaneously removed with cleaving the 
oligonucleotide from the solid support. 
The objectives for functionalising nucleosides are diverse and include but are not limited to 
the development of new binding motifs applied in nanotechnology,
8
 nucleic acid detection for 
clinical and research diagnostics,
9
 inhibiting the transfer of genetic information
10
 and as 
catalysts.
2
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There are multiple places in DNA which can be modified.
10-11
 Firstly the base part of the 
nucleotide can be altered. This can be done by introducing a moiety onto one of the 4 
naturally occurring bases
12
 or changing the base completely.
13
 The sugar moiety can also be 
modified
10, 14
 as well as the phosphate bridges
15
 (Figure 4). These functionalisations should 
not significantly compromise the formation of the double helix.
16
 
 
Figure 4: Possible positions for covalent functionalization of a DNA strand 
By synthesising the oligonucleotide we aim to have some control of the catalytic environment 
where the reaction takes place. This can be done by using a variety of different base 
sequences, by changing the length of the strand and the position in the strand where the 
ligand is situated. The complementary strand can also be adjusted to add to the unique 
surroundings. By having mismatches or making the complementary strand longer or shorter 
than the modified strand, bulges and loops can be created (Figure 5). 
 
Figure 5: Some of the possible motifs that can be created with DNA  
It was theorised that for the transfer of chiral information on to the substrate the transition 
metal should be located within the chiral environment created by the double helix. It was 
suspected that if the modification was to occur on a phosphate bridge or a sugar moiety that 
the transition metal would be situated on the edge of the double helix and therefore will not 
feel the full effect of the chiral environment therefore base modification was selected. 
Phosphine ligands are of interest because they form stable catalytically active complexes with 
a variety of metals. This makes them versatile ligands in catalysis. Moreover phosphines 
coordinate stronger to late transition metals such as Rh and Pd than nitrogen does. As there 
are numerous nitrogens present in nucleic acids this is definitely an advantage and increases 
the probability that only one active site gets formed. Phosphines are not compatible with the 
DNA synthesis as oxidation will occur during the oxidation step required for the formation of 
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the phosphate bridge in the backbone, thus the post-synthesis approach was applied. A linker 
was introduced to attach the phosphine moiety to the oligonucleotide. Ideally the coupling 
method and reagents used as well as the linkage formed during the coupling of the phosphine 
moiety to the linker need to be water compatible. Furthermore it was essential that the utilised 
coupling method  was very efficient and chemoselective.
17
  
2.1.1 CuAAC 
In the early 2000’s Sharpless et al.18 introduced the term click chemistry to describe reactions 
which are modular, highly efficient, wide in scope, stereoselective and which generate only 
environmentally benign by-products. Furthermore these reactions are also required to be 
insensitive to oxygen and water. Reactions which fall into this category include 1,3-dipolar 
cycloadditions,  Diels-Alder reactions, ring opening reactions of strained heterocyclic 
electrophiles by nucleophilic substitution and additions to carbon-carbon multiple bonds such 
as in the Michael addition.  
A multitude of reactions have been employed to modify oligonucleotides such as peptide 
bond formation, Diels-Alder reactions, Staudinger ligations and copper catalysed 1,3-dipolar 
cycloadditions also referred to as the click reaction. The latter is one of the most convenient, 
chemoselective and compatible methods to help functionalise oligonucleotides.
15b
 This 
reaction belongs to the Huisgen’s [2 + 3] cycloaddition family. The uncatalysed reaction has 
been known since 1893
19
 and involves reacting an azide with an alkyne to form a triazole 
(Scheme 2) whereby a mixture of 1,4- and 1,5-regioisomers is formed. The reaction can be 
denoted as an AAC (azide alkyne cycloaddition) reaction. The reaction is exothermic but the 
high activation barrier means that the uncatalysed reaction is slow even at elevated 
temperatures.
20
 
 
Scheme 2: Representation of a 1,3 dipolar cycloaddition 
Although the formation of triazoles via 1,3-cycloadditions is arguably the most useful of the 
Huisgen’s reactions, safety concerns with regard to the azide meant that this reaction did not 
receive the attention it deserved. The reaction has increased in popularity after Sharpless et 
al.
21
 published a regioselective version of this reaction using a copper catalyst (CuAAC) 
which exclusively generates the 1,4-regioisomer. The catalyst is best prepared by reducing 
copper(II) sulfate with ascorbate.
22
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  Scheme 3: Proposed mechanism for the copper catalysed 1,3-dipolar cycloaddition 
The bridging coordination chemistry found with copper-acetylides means that each step in the 
proposed catalytic cycle (Scheme 3) could involve multinuclear copper species.
23
 The cycle 
begins with the coordination of the alkyne to the copper (I) species displacing a ligand (14). 
This step is exothermic (11.7 kcal/mol, 49.0 kJ/mol) when the reaction is carried out in water 
while if it is performed in acetonitrile the reaction was calculated
22
 to be endothermic (0.6 
kcal/mol, 2.5 kJ/mol). The azide then replaces one of the ligands on the copper species and 
binds to the copper via the nitrogen proximal to the carbon (15). The terminal nitrogen can 
then attack the C-2 carbon in the acetylide to form a Cu
III
 vinylidene metallacycle (16).
19, 22
 
This step is endothermic with a calculated barrier of 18.7 kcal/mol (78.3 kJ/mol) in water 
which is considerably lower than the uncatalysed reaction (barrier 26.0 kcal/mol, 108.9 
kJ/mol). An increase of the barrier of 1.4 kcal/mol (5.9 kJ/mol) corresponds to a decrease in 
reaction rate of 1 order of magnitude. The barrier to form the triazolyl-copper intermediate is 
very low. The subsequent proteolysis releases the product and regenerates the catalyst.
22
 
A Cu
II
 species is often used as a catalyst precursor in the CuAAC reaction but the active 
complex is a Cu
I
 species. It is known that some Cu
II
-species can cleave DNA molecules
24
 
therefore Carell et al.
25
 used a Cu
I
-species in their initial test reactions. Unfortunately this 
resulted in multiple products which corresponded to strand breaks. This is not too surprising 
since Cu
I
 is thermodynamically instable and is easily oxidised to Cu
II
.  Therefore inert 
atmospheres and anhydrous solvents are normally employed when utilising Cu
I
 complexes.
26
 
Sodium ascorbate is used as a reducing agent in the CuAAC reaction to continuously convert 
Cu
II
 into Cu
I
. To keep the Cu
I
-complex active without introducing a reducing agent Fokin et 
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al.
26a
 developed, tris-(benzyltriazolylmethyl)amine (TBTA), (Figure 6). When Carell et al. 
25
 used 
TBTA they DNA cleaving was dramatically reduced.  
 
Figure 6: tris-(benzyltriazolylmethyl)amine  
2.1.2 RuAAC 
While the CuAAC reactions provided an efficient method to synthesise 1,4-substitued 1,2,3-
triazoles a method to obtain 1,5-substituted 1,2,3-trizoles was lacking until Fokin et al.
20
 
reported a ruthenium catalysed version of the CuAAC. Unlike with the copper-catalysed 
reaction internal alkynes are also accessible in this reaction. Depending on the ruthenium 
complex used either 1,4- or 1,5-substituted regioisomers could be formed. In most cases the 
yield was extremely low. Pentamethylcyclopentadienyl ruthenium chloride complexes 
(Cp
*
RuClLn) formed an exception.
20
 These complexes were generally very active and formed 
solely the 1,5-substituted adduct.  
 
Scheme 4: Proposed reaction mechanism for the Ruthenium catalysed 1,3-dipolar cycloaddition 
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Since different types of ruthenium complexes (e.g. Cp*RuCl(PPh3)2, Cp*RuCl(COD), 
Cp*RuCl(nbd), and [Cp*RuCl]4) showed catalytic activity it was presumed that the neutral 
[Cp
*
RuCl] intermediate was the catalytically active species (Scheme 4). The alkyne and azide 
replace the spectator ligands forming active species 19. There are 4 possible ruthenium-
alkyne-azide complexes (Figure 7). RuAA1 and RuAA3 generate the 1,5-substituted product 
while RuAA2 and RuAA4 would result in the 1,4-regioisomer.
20
 Looking at the activation 
energies it is clear that RuAA1 is the favoured intermediate and the 1,5-substitued triazole 
the favoured product.  
 
Figure 7:  Possible ruthenium-alkyne-azide complexes with their activation barriers 
The subsequent step, oxidative coupling of the azide and alkyne, is the step that controls the 
regioselectivity. A C-N bond is formed between the more electronegative and less sterically 
hindered carbon of the alkyne and the terminal nitrogen of the azide. Reductive elimination 
of the metallacycle releases the product and completes the cycle (Scheme 4).
20
  
Initial experiments indicated that protic solvents should be avoided although reagents did not 
need to be dried.
20
 Later it was discovered that under certain circumstances the reaction 
proceeded in systems containing water.
27
 
2.1.3 Amide bond coupling 
One of the most important bond types in biological systems is the amide bond. These bonds 
are formed by reacting amines with carboxylic acids. This union does not occur 
spontaneously at ambient temperatures. Therefore either elevated temperatures are used 
and/or a activated carboxylic acid. This activation usually takes place by exchanging the OH 
of the acid for a better leaving group (Figure 8).
28
  
 
Figure 8: Amide bond formation 
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This is done with the help of so-called coupling reagents.  There are numerous coupling 
reagents available (Figure 11) such as: 
1) Carbodiimides e.g.  dicyclohexylcarbodiimide (DCC) 
2) 1H-benzotriazole salts e.g. Benzotriazol-1-yloxyl)tripyrrolidin phosphonium 
hexafluorophosphate (PyBOP) 
3) Other coupling reagents  
Carbodiimides are notorious for causing epimerisation. Koenig and Geiger minimised the 
formation of these by-products by adding the additive, 1-hydroxy-1H-benzotriazole (HOBt). 
HOBt is believed to work by reacting with the carboxylic acid (Figure 9) to form an active 
OBt ester. This stabilises the approach of the amine via hydrogen bonds and thus enhances 
the reactivity. Carbodiimides include dicyclohexylcarbodiimide (DCC), 1,3-
diisopropylcarbodiimide (DIC) and ethyl-(N’,N’-dimethylamino)propyl carbodiimide 
hydrochloride (EDC). 
28
 
 
Figure 9: Activated carboxylic acids 
1H-benzotriazole salts which activate carboxylic acids include uronium/aminium and 
phosphonium salts. These salts form the more reactive OBt ester without the aid of adding an 
additive. When uronium/aminium salts are used the order of addition is crucial as they can 
react with the amine to form a guanidinium by-product (Figure 10). Uronium/aminium salts 
include O-(Benzotriazol-1-yl)-N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU),  
O-(Benzotriazol-1-yl)-N,N’,N’-tetramethyluronium tetrafluoroborate (TBTU). Utilising 
phosphonium salts circumvents this problem. (Benzotriazol-1-yloxy) tris(dimethylamino) 
phosphonium hexafluorophosphate (BOP) was the first phosphonium salt used but because of 
its carcinogenicity the implementation was limited. A less hazardous version was developed 
by replacing the methyl group with pyrrole rings and is known as PyBOP (Benzotriazol-1-
yloxyl)tripyrrolidin phosphonium hexafluorophosphate) (Figure 11).
28
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Figure 10: Guanidinium by-product 
Other couplings reagents include carbonyldiimidazole (CDI). This reagent is commonly used 
in peptide synthesis. With this reagent Sharma showed that it could be used to couple 
unprotected amino acids to amines with moderate yields.
28
  
 
Figure 11: Coupling reagents 
Amide formation has been successfully employed to modify nucleotides.
29
 This method has 
also been used to introduce phosphorus containing moieties into oligonucleotides.
2b, 30
 The 
coupling reagent used for these couplings was EDC.
2b, 30
 In these examples the amine 
functionality is located on the nucleotide. Others in our group were working on this approach 
therefore it was decided to have the carboxylic acid on the nucleotide. 
2.2 Results and discussion 
2.2.1 Synthesis of a modified nucleotide 
In order to see if minor changes in the ligand structure would have an effect on the catalytic 
reaction both a thymidine and uridine alkyne were synthesised. Propargyl bromide was used 
to introduce a terminal alkyne to deoxyuridine (Scheme 5).  During this reaction DMF 
(dimethylformamide) was used as a solvent which proved cumbersome to remove. Most of 
the DMF was removed under reduced pressure to give a sticky viscous oil. Attempts to 
remove the residual DMF, by washing the reaction mixture with water, proved unsuccessful 
because the product was highly soluble in water. This ensured that most of the product ended 
up in the aqueous (aq.) layer along with the DMF. Further purification by flash 
chromatography also failed to remove the DMF. The presence of DMF did not interfere with 
the next step therefore we continued without further purification. 
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Scheme 5:  Synthesis of nucleoside 2 followed by preparation for DNA synthesis 
After coupling the alkyne to a nucleoside (23) the modified nucleoside could then be 
prepared for DNA synthesis (Scheme 5). The 5’-hydroxyl group was first protected with 
DMT before the 3’-hydroxyl group was phosphorylated using 2cyanoethyl N,N-
diisopropylchlorophosphoramidite. Two diastereomers are formed in a ratio of about 1 to 1. 
For incorporation into a DNA strand there is no need to separate the diastereomeric mixture, 
but if separation is required this can easily be achieved by chromatographic methods. 
Our attention was then directed to synthesising a nucleoside with a protected carboxylic acid. 
Methyl acrylate was chosen as the protected carboxylic acid. The methoxy group was not a 
good leaving group but the convenience of it being commerically available outweighed the 
benefits of using a potentially better leaving group.  
The commercially available 2-iodo-5’-deoxyuridine (26) was converted into nucleoside 27 
via a Heck reaction (Scheme 6). The yield of this reaction was moderate to good. Once the 
nucleoside was obtained it was converted into nucleotide 28 using the same methods as 
described for the synthesis of alkyne nucleotide 25. 
 
Scheme 6: Heck coupling with methylacrylate 
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2.2.2 Synthesis of phosphine azides 
Apart from an alkyne, which we placed on the nucleoside, an azide is also required for the 
cycloaddition. This azide was attached to the ligand moiety. In the presence of azides 
phosphines undergo the Staudinger reaction (Figure 12) and therefore the phosphine needs to 
be protected with e.g. a BH3-group. 
 
Figure 12: The Staudinger reaction 
A phosphine moiety containing an azide was reported by Van Maarseveen et al..
31
 Azide 18 
was synthesised (Scheme 7) using this method. First alcohol 30 was synthesised via a 2 step 
procedure reported by He et al..
32
 After protecting diphenylphosphine with BH3, the excess 
BH3SMe2 was removed under reduced pressure and the product was used without further 
purification. The conversion to the alcohol with formaldehyde in presence of a base 
proceeded smoothly and a yield of 98 % was achieved. Alcohol 30 was activated with triflic 
anhydride before reacting with TMGA (N,N,N’,N’-tetramethylguanidinium azide) to afford 
azide 31 as an oil. Unfortunately this azide was not a very stable compound and decomposed 
over time even in the freezer, but it was reasonably stable when stored in benzene at -20 
o
C. 
  
Scheme 7: Azide synthesis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
In order to obtain a more stable compound the chain length between the phosphine and the 
azide was increased (Scheme 8). Like in the synthesis of phosphine azide 31 the first step in 
this reaction was the protection of diphenylphosphine with BH3. This was then lithiated to 
quantitatively give 33, according to 
31
P-NMR, and subsequently reacted with a large excess 
of 1,3-dibromopropane to afford 34 in 91 % yield. Using sodium azide the bromo substituent 
was converted to azide 35.  
 
Scheme 8: Second phosphine azide synthesised 
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Although phosphine azide 35 was more stable than 31 it is still advisable to make a stock 
solution in dioxane and store it in the freezer at -20 °C. 
2.2.3 Oligonucleotide synthesis 
For the synthesis of the oligonucleotides it is important that the coupling proceeds with a high 
efficiency. Table 1 shows the overall yield of oligonucleotides of different lengths with 
different coupling efficiencies. For a 15 mer with a coupling efficiency of 99 % the overall 
yield is still respectable with 86%. If only 90% coupling efficiency is obtained the yield drops 
to 21%. In our case the DNA synthesiser did not work optimally and coupling yields as low 
as 85% were often obtained. 
Table 1: Overall yield with different coupling efficiencies 
X-mer 
(Length of the oligonucleotide strand) 
Coupling efficiency 
99% 98% 90% 
2 99 98 90 
5 95 90 59 
10 90 82 35 
15 86 74 21 
 
A complete turn of the double helix in B-DNA requires a minimum of 10 base pairs. To 
ensure that the double helix remains intact once the modified nucleotide has been introduced 
several bases were added on either side giving a total of 15 nucleotides. A 15 mer was 
synthesised using a DNA synthesiser on a controlled pore glass (CPG) support with a 
succinyl linker. The modified nucleotide was introduced into a 15 mer with a coupling 
efficiency similar to that of natural bases. The coupling efficiency of the subsequent coupling 
was also in line with the efficiency of those preceding it, indicating that the modification did 
not influence coupling efficiency. The final step in the synthesis was the removal of the 
remaining DMT protecting group. In the past the DMT was left on to facilitate the 
purification of the strand and subsequently removed. Purification techniques have improved 
making this extra step obsolete. 
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Modified nucleotide 28 was incorporated into 15mer 36 (Figure 13). The coupling efficiency 
of the modified nucleotide fell into the same range as the “natural nucleotides” so this 
modification did not have any negative effects on the coupling.  
 
Figure 13: Oligonucleotide 36, a 15 mer with nucleotide 28 in the middle 
The normal procedure for cleaving DNA strands from the solid support is heating for several 
hours in aqueous ammonium hydroxide. This method was not compatible with strand 36 
because ammonolysis can potentially take place generating an amide and thus prevent further 
functionalisation. 
A 0.5 M solution of sodium hydroxide in a methanol/water mixture was used instead. After 
removing the solid support, via filtration, the reaction mixture was neutralised with HCl 
before purifying via preparative HPLC using a reverse phase column. 
A MALDI (Matrix-Assisted Laser Desorption Ionisation) spectrum (Figure 14) was taken of 
this strand and a mass of 4670 was observed which corresponded to the protonated expected 
mass (Mw = 4669). 
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Figure 14:: MALDI spectrum of oligonucleotide 36 
Another mass was also detected at 2336 Dalton (D). It is unclear what the mass indicates as it 
does not correspond to a shorter strand nor is it doubly charged. 
An attempt was made to remove the methoxy protecting group which resulted in only partial 
deprotection. Different deprotection methods still need to be attempted if this remains 
unsuccessful the leaving group should be altered. 
A trimer was also synthesised. Because there were only two coupling steps involved it could 
easily be synthesised manually. This had the added advantage that larger amounts can be 
synthesised. An efficient method to synthesise oligonucleotides manually in solution was 
reported in 2006 by Vander Marel and co-workers.
33
 Using this method they synthesised a 6-
mer. Therefore we decided to use this method to synthesise a trimer with a non-natural 
nucleotide containing an alkyne at the central position (Scheme 10). 
This synthesis takes place in solution and consequently the 3’ hydroxyl group of the first 
monomer was not protected by a solid support. To prevent unwanted side-reactions taking 
place this group was protected by an adamantylacetyl-group (Ada-group). This group, like all 
the protecting groups on the bases, not only protects the reactive moiety but also enhances the 
solubility of the growing strand in the organic solvents. This was of paramount importance as 
the work up between coupling steps involves washing with an aqueous solution. 
Thymidine was chosen as the first nucleotide. As in the case of preparation of the nucleotide 
for DNA synthesis on solid support the 5’hydroxyl was protected first with a DMT group 
generating 37 in 89% yield. Once the DMT group was in place the 3’ hydroxyl group could 
be protected using AdaOH affording compound 38 in 79 % yield. To increase the solubility 
in organic solvents further a chloromethylpivalate (POM) group was attached to the amino 
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functionality present on the thymidine base. The DMT group was subsequently removed to 
allow for coupling to a subsequent nucleotide (Scheme 9).  
 
Scheme 9: Synthesis of the first nucleotide for the solution phase synthesis of oligonucleotides 
The first step in synthesising trimer 45 involved coupling nucleotides 40 and 25 together with 
the help of DCI as activator (Scheme 10). After complete conversion, the phosphoramidite 
was oxidised using iodine in THF/pyrindine. The excess of 25 was washed away before the 
DMT group was removed. Dimer 42 was washed before adding dG-phosphoramidite and 
repeating the steps. Once the DMT group was removed from the trimer the protecting groups 
were removed by heating at 55°C in ammonium hydroxide for 3 days. The ammonium 
hydroxide was removed under reduce pressure. The majority of the protecting groups were 
subsequently removed by adding water and allowing them to precipitate out of solution 
before purifying by chromatography over reverse phase silica gel. 
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Scheme 10: Synthesis of a trimer in solution 
2.2.4 The 1,3 dipolar cycloaddition 
The 1,3-dipolar cycloaddition was carried out with monomer 23, trimer 45 and a 15 mer. 
Monomer 23 and trimer 45 were synthesised via the 1,3 dipolar cycloaddition by making the 
copper catalyst in situ (Scheme 11). The next stage involved removing the BH3 group. 
Monomer 23b and trimer 45b were selected for testing deprotection conditions. The BH3 on 
the monomer could easily be removed with DABCO (1,4-diazabicyclo[2.2.2]octane), a 
strongly basic diamine, in organic solvents but when the solvent was changed to water no 
deprotection occurred. TCEP (tris(2-carboxyethyl)phosphine) in an aqueous buffer (pH = 12) 
was subsequently tried. This also removed the BH3 group on the monomer but when this was 
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tried with the trimer the BH3 group remained. Refluxing in methanol overnight however, 
resulted in the removal of the BH3 group in both the monomer and trimer. 
 
Scheme 11: 1,3 cycloaddition with a monomer and trimer 
With the 15 mer the copper catalyst was pre-formed by reacting CuSO4 with ascorbate in the 
presence of TBTA, as stabilising agent, before adding it to the alkyne/azide mixture. 
Unfortunately no product formation could be detected with MALDI TOF. 
2.3 Conclusion 
By lengthening the carbon chain of the phosphine azide 31 to form compound 35 a more 
stable azide could be synthesised. Although 35 is more stable it is recommended to store it in 
solution, under argon at -20 °C. The compound remained stable in a solution of dioxane for 
several years under these conditions. 
Nucleosides and small oligonucleotides containing an alkyne functionality could be 
synthesised and after which reacted with compound 35 to afford the 1,3-cycloaddition 
products 46 and 47. Normal procedures for the removal of the BH3-group involve heating in 
the presence of amines. This worked for the monomer but when the solvent was changed to 
water the amines were insufficiently nucleophilic to remove the BH3. Methanol proved to be 
successful in the removal of the BH3 group present on the trimer. 
The 1,3-dipolar cycloaddition did not work on the 15-mer when CuSO4 was used as copper 
source. Using a different copper source could potentially remedy this problem. 
Methyl groups are ideal carboxylic acid protecting groups however initial attempts to remove 
this functionality resulted in only partial deprotection. Increasing reaction times or changing 
the deprotection conditions might solve the problem otherwise a different protecting group 
should be considered. 
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2.4 Experimental 
General Procedures 
All air- and water-sensitive reactions were carried out under argon utilising standard Schlenk 
techniques. Chemicals were purchased from Sigma Aldrich, Acros, Link Technologies, 
Fisher Scientific, Strem and Glen Research and used as is unless otherwise stated.  Pyridine, 
dichloromethane, acetonitrile and diisopropylethylamine were distilled from CaH2. CDCl3 
was distilled from CaCl2 and stored under argon over K2CO3. Acetone was distilled from 
K2CO3. Methanol and ethanol were distilled over Mg/I2, Dioxane was distilled over sodium, 
THF and diethyl ether were distilled over sodium/benzophenone. All the distilled solvents 
were stored under argon or nitrogen. Dry DMF was purchased and transferred into a youngs 
ample. Organic solvents were degassed by three freeze/thaw cycles. Aqueous solutions were 
degassed by bubbling argon or nitrogen through for several hours.   
Thin Layer Chromatography (TLC) was performed using silica plates (plates (polygram 0.3 
mm silica gel with fluorescent indicator UV254 on aluminium plates) purchased from Merck. 
Compounds on TLC were visualised by UV-detection unless otherwise stated. Flash 
chromatography or purification via a chromatotron
TM
 were performed using the indicated 
eluent. The silica used for flash chromatography was silica gel 60 mesh 70-230 and was 
purchased from Fluka.  
NMR spectra were recorded at room temperature on a Bruker Avance NMR spectrometer 
(300,400 or 500 MHz). Chemical shifts () are given in ppm. Shifts are relative to a TMS 
reference (
1
H or 
13
C) or an 85% H3PO4 reference (
31
P). 
13
C and 
31
P spectra were measured 
with 
1
H decoupling unless otherwise stated.  
Oligonucleotides were synthesised on an Applied Biosystems 392 DNA/RNA synthesizer 
using protocols obtained from Applied Biosystems. WHATMAN 0.2 m PTFE syringe 
filters were used to separate the oligonucleotides from the solid support and the released 
water-insoluble protecting groups. HPLC purification was performed on a Waters machine 
equipped with a waters 2700 sample manager, Waters 600 controller and waters 2487 dual 
absorption detector. The column used was a Phenomenex Clarity C18 5 oligo-RP column 
(250 x 21.20 mm) monitoring wavelength 260 nm. 
FPLC purification was carried out on a FPLC Akta Basic 100 (P-901). The column used was 
a HiLoad 16/10 Q Sepharose HP column. Monitoring was done via a UV-900 at 260 nm. 
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3-(2-Propyn-1-yl)thymidine (23b)  
An 80% solution of propargyl bromide in THF (0.75 ml, 8.4 mmol) was 
added to a solution of thymidine (1.22 g, 5.05 mmol) and potassium 
carbonate (1.9 g, 13.75 mmol) in DMF/acetone (25 ml, 1:1). The reaction 
mixture was stirred at   50 
o
C for 3 days. The reaction mixture was filtered and evaporated to 
remove most of the solvents. The product was purified by column chromatography (eluent: 
DCM/acetone 1:1 volume/volume (v/v)). DMF was still present. The product was obtained as 
a yellowish oil.  Yield  61 %  (0.85 g, 3.03mmol). 
Characterisation agreed with the literature.
34
  
1
H NMR (300 MHz, D2O): δH = 1.80 (3H, s, CH3), 2.10 (1H, s, CH≡), 2.23-2.32 (2H, m, H-
2’), 3.60-3.76 (2H, m, H-5’), 3.88-3.97 (1H, m, H-3’), 4.29-4.38 (1H, m, H-4’), 4.56 (2H, s, 
NCH2), 6.20 (1H, t,  
3
J  = 6.6 Hz, H-1’), 7.56 (1H, s, H-6)   
13
C NMR (75 MHz, D2O): ôC = 12.16, 30.67, 38.79, 61.07, 70.36, 71.79, 77.92, 85.95, 86.56, 
110.56, 135.82, 150.88, 164.41;  
3-(2-Propyn-1-yl)uridine (23a)  
Compound 23a was synthesised using the same procedure describe above. 
The product was obtained as a yellowish oil. Yield 87% (4.96 g, 18 mmol). 
Characterisation agreed with the literature.
12
 
1
H NMR (300 MHz, MeOD): δH 2.19-2.44 (2H, m, H-2’),  2.58 (1H, t,
 3
J = 2.3 Hz, CH≡),  
3.72-3.84 (2H, m, H-5’), 3.95-4.00 (1H, m, H-3’), 4.40-4.45 (1H, m, H-4’),  4.46 (2H, d, J = 
2.3 Hz, NCH2),5.84 (1H, d, J = 8.1 Hz, H-5) 6.28 (1H, t,  
3
J  = 6.6 Hz, H-1’), 8.01 (1H, d, 8.1 
Hz, H-6) 
13
C NMR (75 MHz, CDCl3): δC = 31.3, 41.5, 62.9, 72.2, 72.4, 79.4, 87.7, 89.0, 102.2, 141.2, 
151.7,164.0  
5-(2-carbomethoxyvinyl)-2’-deoxyuridine (27)  
Methyl acrylate (1.7 ml, 17.8 mmol) was added to a stirred solution of 5-
iodo-2’-deoxyuridine (2.05 g, 5.78 mmol), PPh3 (213.46 mg, 0.81 mmol), 
Pd(OAc)2 (91.06 mg, 0.41 mmol) and Amberlite IRA-67 (5.02 mg) in dry, 
degassed DMF (50 ml) at 60 
o
C. The yellow reaction mixture was heated at 80 
o
C overnight 
resulting in a dark brown or green suspension. The solution was allowed to cool to rt. before 
filtering over a silica plug topped with celite, eluting with methanol-DCM (1:3 v/v). The 
filtrate was concentrated in vacuo to afford an orange/brown oil and purified by flash 
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chromatography (MeOH:DCM 1:9 v/v, Rf = 0.28). Compound 27 was obtained as a white 
solid in 66 % yield (1.134 g, 3.6 mmol). 
Characterisation agreed with the literature.
35
  
1H NMR (300 MHz, CD3OD): δH = 2.13-2.27 (2H, m, H-2’), 3.39 (3H, s, CH3), 3.77 (2H, 
m, H-5’), 3.85 (1H, m, H-4’), 4.32 (1H, dt, 3J = 3.5 Hz, 3J = 6.1 Hz, H-3’), 6.16 (1H, t, 3J = 
6.4 Hz, H-1’), 6.80 (1H, d, 3J = 15.9 Hz, CHCHCO2Me), 7.30 (1H, d, 3J = 15.9 Hz, 
CHCHCO2Me), 8.40 (1H, s, H-6).      
5-(2-carbomethoxyvinyl)-5’-(O-4,4’-dimethoxytrityl)-2’-
deoxyuridine 
5-(2-carbomethoxyvinyl)-2’-deoxyuridine (27) (1.01 g, 3.2 mmol) was 
azeotropically dried with pyridine (3x 4 ml) and then dissolved in 
pyridine (16 ml). To this stirred solution 4,4’-dimethoxytrityl chloride (1.19 g, 3.51 mmol) 
was added. The resulting mixture was stirred at rt. until the reaction was complete. Methanol 
(3.2 ml) was added to the reaction mixture and stirring continued for a further 30 min. The 
reaction mixture was then concentrated to dryness in vacuo and the residue was dissolved in 
ethyl acetate (170 ml) and washed with 5 % weight/weight (w/w) aq. NaHCO3 (2x 40 ml). 
The organic layer was dried over Na2SO4, filtered and concentrated in vacuo. The compound 
was purified by flash chromatography whereby the silica was treated with a mixture of 
hexane:ethyl acetate:triethyl amine (2:3:0.05) before the compound was brought onto the 
column (eluent: hexane:ethyl acetate 2:3). The product was afforded as a white foam in 75 % 
yield (1.49 g, 2.4 mmol, Rf = 0.24). 
Characterisation agreed with the literature.
35
  
 
1
H NMR (400 MHz, CDCl3): δH = 2.20 -2.25 (1H, m, H-2’), 2.44-2.50 (1H, m, H-2’), 3.35-
3.36 (2H, m, H-5’), 3.60 (3H, s, CO2CH3), 3.71 (6H, s, Ar-OCH3), 4.05 (1H, m, H-4’), 4.45 
(1H, m, H-3’), 6.20 (1H, t, 3J = 6.5 Hz, H-1’), 6.77-6.93 (6H, m, Ar-H and CHCHCO2Me), 
7.21-7.45 (9H, m, Ar-H and CHCHCO2Me), 7.77 (1H, s, H-6) and 8.59 (1H, s, NH). 
3-(2-Propyn-1-yl)-5’-(O-4,4’-dimethoxytrityl)-thymidine (24b)  
3-(2-propyn-1-yl)thymidine (23b) (0.62 g, 2.23 mmol) was azeotropically 
dried with pyridine (3x 1 ml) and then dissolved in pyridine (10 ml).        
4,4’-Dimethoxytrityl chloride (0.83 g, 2.45 mmol) was added to this stirred 
solution. The resulting mixture was stirred at rt. until the reaction was complete. Methanol 
(2.8 ml) was added to the reaction mixture and stirred for a further 30 min. The reaction 
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mixture was then concentrated to dryness in vacuo and the residue was dissolved in ethyl 
acetate (120 ml) and washed with 5 % w/w aq. NaHCO3 (2x 30 ml) followed by brine (30 
ml). The organic layer was dried over Na2SO4, filtered and concentrated under reduced 
pressure. The compound was purified by flash chromatography whereby the silica was 
treated with a mixture of acetone:DCM:triethyl amine (1:4:0.05) before the compound was 
brought onto the column. Eluent acetone:DCM 1:4. 
The product was obtained as a white foam. Yield 66% (0.86 g, 1.48 mmol). 
Characterisation agreed with the literature
36
 
1
H NMR (400 MHz, C6D6): δH = 1.66 (3H, s, NCH3), 1.76-1.77 (1H, m, CH≡), 1.90-1.96 
(2H, m, H-2’), 3.18-3.22 (1H, m, H-5’), 3.28 (6H, s, Ar-OCH3), 3.39-3.43 (1H, m, H-5’), 
3.79-3.80 (1H, m, H-4’), 4.05-4.07 (1H, m, H-3’), 4.60 (2H, dq, J = 2.5 Hz, J = 4.5 Hz, 
NCH2), 6.50 (1H, m, H-1’), 6.74-6.77 (4H, m, Ar-H), 7.03-7.20 (3H, m, Ar-H), 7.34-7.38 
(5H, m, H-6’ and Ar-H), 7.50-7.53 (2H, m, Ar-H) 
13
C NMR (100 MHz, C6D6): δC = 11.5, 29.4, 40.2, 54.2, 62.4, 69.5, 70.9, 84.5, 85.2, 85.9, 
109.3, 112.2, 126.1, 127.0, 127.1, 129.1, 133.1, 134.3, 135.1, 143.3, 148.4, 149.2, 157.7, 
161.5 
3-(2-Propyn-1-yl)-5’-(O-4,4’-dimethoxytrityl)-uridine (24a) 35 
Compound 24a was synthesised using the same procedure describe above. 
The product was obtained as a white foam. Yield 82% (6.72 g, 11.89 mmol) 
Characterisation agreed with the literature.
12
 
3-(2-Propyn-1-yl)-5’-(O-4,4’-dimethoxytrityl)-thymidine-3’-(O-2-
cyanoethyl-N,N-diisopropylamino)phosphoramidite (25b) 
A 1 M solution of 2-cyanoethyl diisopropylchlorophosphoramidite in 
acetonitrile (1.2 ml, 1.16 mmol) was added drop wise to a stirred solution 
of compound 24b (0.52 g, 0.89 mmol) and diisopropylethylamine (290 μl, 
1.78 mmol) in DCM (10 ml) at 0 
o
C. The cooling was removed and the reaction mixture was 
left to stir at rt. for 2 h. Ethyl acetate (30 ml), pre-washed with 5% aq. NaHCO3, was added to 
the reaction mixture and washed with 5% aq. NaHCO3 (2x 25 ml) followed by brine (2x 25 
ml). The organic phase was dried over Na2SO4, filtered and concentrated under reduced 
pressure to afford the crude product as a white foam. The compound was purified by 
chromatotron
TM
. The plate was first treated with diethyl ether:hexane:triethyl amine 4:1:0.5 
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before bringing the compound onto the plate. Eluent diethyl ether:hexane 4:1. The product 
was obtained as a white foam in 37 % yield (0.27 g, 0.33 mmol). 
Characterisation agreed with the literature
36
 
1
H NMR (300 MHz, CDCl3) diastereomer A: δH =  0.82-0.90 (2H, m, i-Pr-CH), 1.07 (3H, s, 
i-Pr-CH3), 1.17 (9H, s, i-Pr-CH3), 1.46 (3H, s, NCH3), 2.17 (1H, t, 
4
J = 3 Hz, CH≡), 2.28-
2.59 (2H, m, H-2’), 3.25-3.35 (1H, m, H-5’), 3.44-3.67 (5H, m, H-5’ and CH2-CH2CN), 3.79 
(3H, s, 2x Ar-OCH3), 4.17-4.20 (1H, m, H-4’), 4.61-4.68 (1H, m, H-3’), 4.72 (2H, d, 
4
J = 3 
Hz, NCH2), 6.45 (1H, t, 
3
J = 6 Hz, H-1’), 6.84-6.85 (4H, m, Ar-H), 7.24-7.32 (4H, m, Ar-H), 
7.37-7.39 (2H, m, Ar-H), 7.67 (1H, d, 
3
J = 1.1 Hz, H-6). 
1
H NMR (300 MHz, CDCl3) diastereomer B: δH =  0.82-0.90 (2H, m, i-Pr-CH), 1.05 (3H, s, 
i-Pr-CH3), 1.15 (9H, s, i-Pr-CH3), 1.46 (3H, s, NCH3), 2.17 (1H, t, 
4
J = 3 Hz, CH≡), 2.28-
2.59 (2H, m, H-2’), 3.25-3.35 (1H, m, H-5’), 3.44-3.67 (5H, m, H-5’ and CH2-CH2CN), 3.79 
(3H, s, 2x Ar-OCH3), 4.13-4.16 (1H, m, H-4’), 4.61-4.68 (1H, m, H-3’), 4.72 (2H, d, 
4
J = 3 
Hz, NCH2), 6.47 (1H, t, 
3
J = 6 Hz, H-1’), 6.80-6.82 (4H, m, Ar-H), 7.24-7.32 (4H, m, Ar-H), 
7.40-7.42 (2H, m, Ar-H), 7.62 (1H, d, 
3
J = 1.1 Hz, H-6). 
31
P (121 MHz, CDCl3): δP = 149.6 (s), 150.2 (s). 
3-(2-Propyn-1-yl)-5’-(O-4,4’-dimethoxytrityl)-thymidine-3’-(O-2-
cyanoethyl-N,N-diisopropylamino)phosphoramidite (25a) 
Compound 25a was synthesised using the same procedure describe above. 
Product was obtained as a white foam. Yield 87% % (4.96 g, 18.6 mmol) . 
Characterisation agreed with the literature.
12
 
1
H NMR (300 MHz, CDCl3) diastereomer A: δH = 1.11 (12 H, d, 6.8 Hz), 2.11 (1H, t, J = 2.4 
Hz), 2.17-2.25 (1H, m), 2.38-2.49 (3H, m), 3.28-3.39 (2H, m), 3.49-3.67 (4H, m), 3.71 (6H, 
s), 4.09 (1H, m), 4.55 (2H, d, J = 2.4 Hz), 4.57-4.64 (1H, m), 5.35 (1H, d, J = 8.2 Hz), 6.22 
(1H, t, J = 6.3 Hz), 6.75-6.78 (4H, m), 7.14-7.35 (9H, m), 7.69 (1H, d, J = 8.2 Hz) 
13
C NMR (75 MHz, CDCl3) diasteromer A: C = 24.7, 24.8, 30.2,43.6, 43.8, 55.6, 63.0, 86.2, 
113.6, 127.4, 128.3, 128.5, 130.5,135.6, 135.8, 159.2 
31
P NMR (121 MHz CDCl3) diastereomer A: P = 149.0 
1
H NMR (300 MHz, CDCl3) diastereomer B: δH = 1.05 (12 H, dd, 6.8, 23 Hz), 2.11 (1H, t, J 
= 2.4 Hz), 2.14-2.26 (1H, m), 2.46-2.57 (3H, m), 3.26-3.33 (2H, m), 3.44-3.79 (4H, m), 3.70 
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(6H, s), 4.01-4.06 (1H, m), 4.54 (2H, d, J = 2.4 Hz), 4.55-4.62 (1H, m), 5.34 (1H, d, J = 8.2 
Hz), 6.22 (1H, t, J = 6.4 Hz), 6.72-6.78 (4H, m), 7.13-7.34 (9H, m), 7.64 (1H, d, J = 8.2 Hz) 
13
C NMR (75 MHz, CDCl3) diasteromer B: C = 21.1, 25.0, 25.1, 30.7,41.1, 43.9, 44.1, 56.0, 
58.9, 59.2,  63.6, 70.8, 73.7, 74.0, 79.2, 86.0,86.5, 87.6, 114.0, 118.5, 127.8, 128.7, 128.8, 
130.9,136.0, 136.2, 139.2, 145.3,151.0,159.6, 162.2 
31
P NMR (121 MHz CDCl3) diastereomer B: P = 148.7 
5-(2-carbomethoxyvinyl)-5’-(O-4,4’-dimethoxytrityl)-2’-
deoxyuridine-3’-(O-2-cyanoethyl-N,N-
diisopropylamino)phosphoramidite (28)  
A 1 M solution of 2-cyanoethyl diisopropylchlorophosphoramidite in 
acetonitrile (1.2 ml, 1.2 mmol) was added drop wise to a stirred solution 
of 5-(2-carbomethoxyvinyl)-5’-(O-4,4’-dimethoxytrityl)-2’-deoxyuridine (462.34 mg, 0.75 
mmol) and diisopropylethylamine (0.3 ml, 1.73 mmol) in DCM (15 ml) at -78 
o
C. The 
cooling was removed and the reaction mixture was left to stir at rt. for 2 h. Ethyl acetate     
(15 ml), pre-washed with 5% aq. NaHCO3, was added to the reaction mixture and washed 
with 5% aq. NaHCO3 (2x 15 ml) followed by brine (15 ml). The organic phase was dried over    
Na2SO4, filtered (eluting with DCM) and concentrated in vacuo to afford the crude product as 
a white foam. The compound was purified by chromatotron (eluent: hexane:ethyl acetate 1:4, 
Rf = 0.86). The plate was first treated with hexane:ethyl acetate:triethyl amine 1:4:0.5 before 
bringing the compound onto the plate. The product was obtained as a white foam in 49 % 
yield (300 mg, 0.37 mmol). 
1
H NMR (400 MHz, C6D6): δH = 1.09 (2H, m, CH(CH3)2), 1.16-1.24 (12H, m, i-Pr-CH3), 
1.80-1.83 (1H, m, CH-Me2), 1.91-1.94 (1H, m, CH-Me2), 2.32-2.43 (1H, m, H-2’), 2.57-2.75 
(1H, m, H-2’), 3.20-3.48 (2H, m, H-5’), 3.53 (9H, s, 2x ArOCH3 and CO2CH3), 3.57-3.63 
(4H, m, CH2-CH2-CN), 4.39-4.44 (1H, m, H-4’), 4.83-4.86 (1H, m, H-3’), 6.32-6.37 (1H, m, 
H-1’), 6.99 (4H, d 3J = 8.8 Hz, Ar-H), 7.21 (1H, m, CHCO2), 7.22-7.42 (3H, m, Ar-H), 7.58-
7,78 (8H, m, 6H Ar-H and H-1’ and CH=C). 
31
P (162 MHz, CD3OD): δP = 149.00 (s), 148.66 (s). 
Diphenylphosphino(borane)methane alcohol (30)  
Diphenylphosphine (1.1 ml, 6.3 mmol) was added in one go to a cooled (-70 °C)     
2 M solution of borane dimethyl sulfide (4 ml, 8.0 mol) in THF. The reaction mixture was 
allowed to warm to room temperature. After 2 h the excess borane dimethyl sulphide 
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complex was removed under reduced pressure.  The residue was dissolved in 8 ml of THF. 
Formaldehyde (4 ml, 37 %) and potassium hydroxide (0.58 g, 10.2 mmol) were added turning 
the solution cloudy. After a couple of minutes the solution cleared up. After 3 h the THF was 
removed under reduced pressure and subsequently extracted 3 times with ethyl acetate (10 
ml). The combined organic layers were washed twice with brine (8 ml) and dried over 
Na2SO4. The compound was further purified by flash chromatography (eluent ethyl 
acetate:petroleum ether 2:5). 
The product was obtained as a whitish oil. Yield 98 % (1.42 g, 6.17 mmol). 
Characterisation agreed with the literature.
31
  
1
H NMR (400 MHz, CDCl3): δH = 0.61-1.26 (3H, m, BH3), 4.45 (2H, s, CH2), 7.45-7.56 (6H, 
m, Ar-H), 7.70-7.75 (4H, m, Ar-H). 
31
P NMR (162 MHz, CDCl3):
 δP = 17.45 (q, 
2
J = 55 Hz). 
Azidomethyl(diphenyl)phosphine borane complex (31) 
To a solution of 30 (0.44 g, 1.9 mmol) in chloroform (8 ml, filtrated over alumina) 
at –60 °C Tf2O (0.45 ml, 2.7 mmol) and 2,6-lutidine (0.4 ml. 3.4 mmol) were added. The 
solution was stirred for 3 hours before adding tetramethylguanidinium azide (TMGA, 1.0 g, 
6.6 mmol). The mixture was stirred overnight and allowed to warm to rt. After 24 h saturated 
aqueous ammonium chloride (50 ml) was added and the mixture was extracted 3 times with 
DCM (25 ml). The combined organic layers were washed with water (2 x 25 ml) and once 
with brine (25 ml).The organic layer was dried over Na2SO4 and concentrated under reduce 
pressure. The residue was purified by flash chromatography (diethyl ether:petroleum ether 
1:7 Rf = 0.28). The product was obtained as a pale yellow oil in an 80% yield (387 mg, 1.52 
mmol). 
Characterisation agreed with the literature.
31
 
!! BE AWARE POTENTIONALLY EXPLOSIVE!! 
 
1
H NMR (300 MHz), CDCl3); δH =  0.57-1.52 (3H, m, BH3), 4.04 (d, J = 3.4, 2H, CH2), 
7.46-7.60 (m, 6H, Ar-H), 7.71-7.78 (m, 4H, Ar-H) 
31
P NMR (121 MHz, CDCl3); δ (ppm) = 19.8 (b). 
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Borane (30bromopropyl)diphenylphosphine (34) 
Diphenylphosphine (9.1 ml, 52.4 mmol) was added in one go to a cooled 2 M 
solution of borane dimethyl sulfide (55 ml, 110 mmol) in THF. The reaction mixture was 
allowed to warm to room temperature. After 2 h the excess borane dimethyl sulphide 
complex was removed under reduced pressure. The reaction mixture was subsequently 
dissolved in 200 ml of THF and cooled to -70 °C before dropwise adding a 2.5M solution of 
n-BuLi (22 ml, 55 mmol).  
In a separate flask 1,3-dibromopropane (50 ml, 494 mmol) was dissolved in 100 ml of THF 
and cooled to -65 °C. The borane diphenylphosphine from the previous step was added to this 
solution via a cannula and the reaction mixture was allowed to warm to room temperature 
overnight. The reaction mixture was quenched with water (50 ml) before diluting with DCM 
(50 ml). The two layers were separated and the aqueous layer was extracted 3 times with 
DCM (3 x 50ml). The combined organic layers were washed with water (25 ml) and brine 
(25 ml) and dried over MgSO4. The solvent and excess 1,3-dibromopropane were removed 
under reduced pressure. The reaction mixture was dissolved in refluxing hexane before 
precipitating the product out by cooling in a dry ice bath. 
The product was obtained as a white solid. Yield 12.6 g (75%). 
1
H NMR (300 MHz, CDCl3): δH 0.50-1.44 (3H, bm, BH3), 2.01-2.14 (2H, m, 
 
CH2), 2.34-2.44 
(2H, m, CH2), 3.45 (2H, t, 
3
J  = 6.5 Hz, CH2-Br), 7.42-7.53 (6H, m, Ar-H), 7.66-7.72 (4H, m, 
Ar-H) 
13
C NMR (75 MHz, CDCl3): δC 24.4, 26.1, 34.3, 128.6, 131.3, 132.1  
31
P NMR (121 MHz, CDCl3): δP 15.7 (b) 
HRMS cald. for C15H16BrP (M-BH3) 306.0168 found 306.0165 
Borane (3-azidoproyl)diphenylphosphine (35) 
Compound 34 (5.13 g, 16.7 mmol) was dissolved in degassed DMF (50 ml). 
Sodium azide (2.03 g, 31.2 mmol) was dissolved in degassed water (20 ml) before adding to 
the solution of compound 34. The reaction mixture was warmed to 50 °C for 24 hours. The 
product was extracted with diethyl ether (3 x 100 ml) and dried over MgSO4. The crude 
reaction mixture was purified by flash chromatography using silica gel. Eluent petroleum 
ether: diethyl ether 7:2. The product was obtained as a cloudy oil.  
Yield 2.04 g (43 %).  
!! BE AWARE POTENTIONALLY EXPLOSIVE!! 
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1
H NMR (300 MHz, CDCl3): δH = 0.51-1.44 (3H, bm, BH3), 1.74-1.87 (2H, m, 
 
CH2CH2CH2), 2.25-2.34 (2H, m, PCH2), 3.36 (2H, t, 
3
J  = 6.4 Hz, CH2-N3), 7.42-7.54 (6H, 
m, Ar-H), 7.65-7.73 (4H, m, Ar-H) 
13
C NMR (75 MHz, CDCl3): δC = 22.5 (CH2CH2CH2), 23.0 (PCH2), 51.9 (CH2-N3), 128.9 
(Ar), 131.4 (Ar), 132.0(Ar) 
31
P NMR (121 MHz, CDCl3): δP = 15.9 (b) 
5’-O-dimethoxytrityl-deocythmidine (37) 
The compound was synthesised via the same procedure as compound 24. 
The product was obtained as a white foam. Yield 85% (13.8 g, 25.4 mmol). 
Characterisation agreed with the literature.
33
 
1
H NMR (400 MHz, CDCl3): δH = 1.33 (3H, s, Me), 2.20-2.23 (1H, m, 3’ or 4’), 2.34-2.38 
(1H, m, 3’ or 4’), 3.24-3.36 (2H, ddd 3J = 3.1 Hz, 3J = 10.5 Hz, 3J = 20.8 Hz, 2’), 3.65 (6H, s, 
OMe), 4.00-4.02 (1H, m,) 4.5-4.53 (1H, m) 6.36 (1H, t 
3
J = 6.9 Hz, 1’), 6.72 (4H, d 3J = 8.9 
Hz, Ar), 7.13-7.23 (7H, m, Ar), 7.31-7.33 (2H, m, Ar), 7.53 (1H, s, 6) 
13
C NMR (100.6 MHz, CDCl3): δC = 10.8, 39.9, 44.7, 54.2, 62.7, 71.4, 83.8, 85.4, 85.8, 
110.2, 112.2, 126.0, 126.9, 127.1, 129.1, 134.4, 134.9, 143.4, 149.8, 157.6, 163.3 
3’-O-adamantaneacetyl-5’-O-dimethoxytrityldeoxythymdine (38) 
Compound 38 was synthesised according to the literature procedure.
33
 
The compound was obtained as a white foam. Yield 79% (3.67 g, 5.1 mmol). 
Characterisation agreed with the literature.
33
 
1
H NMR (400 MHz, CDCl3): δH = 1.30 (3H,s), 1.52-1.63 (12H, m), 1.88 (3H, bs), 2.20-2.01 
(2H, bs), 2.34-2.40 (2H, m), 3.40 (1H- m), 3.70 (6H), 4.04-4.06 (1H, m,) 5.37-5.38 (1H, m) 
6.37 (1H, t 
3
J = 7.1 Hz, 1’), 6.75 (4H, d 3J = 8.7 Hz), 7.13-7.23 (7H, m), 7.31-7.33 (2H, m), 
7.53 (1H, s), 9.47 (1H, bs) 
13
C NMR (100.6 MHz, CDCl3): δC = 10.6, 27.5, 32.0, 35.6, 37.0, 41.4, 47.6, 54.2, 62.7, 73.7, 
83.2, 83.4, 86.1, 110.6, 112.3, 126.2, 127.0, 127.1, 129.1, 134.2, 134.7, 134.8, 143.2, 149.7, 
157.7, 162.9, 170.2 
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3’-O-adamantaneacetyl-5’-O-dimethoxytrityl-N-pivaloyloxymethyl-
deoxythymdine (39) 
Compound 39 was synthesised according to the literature procedure.
33
 
The compound was obtained as a white foam. Yield 79% (3.36 g, 4.0 
mmol). 
Characterisation agreed with the literature.
33
 
1
H NMR (400 MHz, CDCl3): δH = 1.10 (9H, s), 1.33 (3H, s), 1.50-1.62 (12H, m), 1.87 (3H, 
bs), 1.99 (2H, s), 2.37-2.40 (2H, m), 3.40 (2H- m), 3.68 (6H, s), 4.05-4.07 (1H, m,) 5.37-5.40 
(1H, m), 5.84-5.89 (2H, m) 6.38 (1H, t 
3
J = 7.1 Hz, 1’), 6.75 (4H, d 3J = 8.9 Hz), 7.12-7.16 
(1H, m) 7.19-7.22 (6H, m), 7.30-7.33 (2H, m), 7.56 (1H, s) 
13
C NMR (100.6 MHz, CDCl3): δC = 10.5, 25.3, 26.7, 31.2, 34.9, 36.3, 37.0, 40.7, 46.8, 53.4, 
61.8, 63.4, 72.8, 83,3, 85.4, 108.9, 111.5, 125.4, 126.4, 128.3, 132.7, 133.4, 133.5, 142.5, 
148.6, 157.0, 160.7, 165.4, 175.7 
3’-O-adamantaneacetyl- N-pivaloyloxymethyl-deoxythymdine (40) 
Compound 40 was synthesised according to the literature procedure.
33
 
The compound was obtained as a white foam. Yield 65 % (1.44 g, 2.7 
mmol). 
Characterisation agreed with the literature.
33
 
1
H NMR (400 MHz, CDCl3): δH = 1.11 (9H, s), 1.53-1.66 (12H, m), 1.90 (3H, bs), 2.03 (2H, 
s), 2.31-2.35 (2H, m), 3.87 (2H- m), 4.03-4.05 (1H, m,), 5.26-5.30 (1H, m), 5.85-5.91 (2H, 
m) 6.25 (1H, t 
3
J = 7.3 Hz), 7.61 (1H, s) 
13
C NMR (100.6 MHz, CDCl3): δC = 13.2, 27.0, 28.5, 33.0, 36.6, 37.5, 38.8, 42.4, 48.6, 62.5, 
65.1,74.2, 85.3, 86.2, 110.5, 135.3, 150.4, 162.6, 171.6, 177.7 
General procedure for solution phase synthesis of trimers.
33
 
Compound 40 (237 mg, 0.45 mmol) and nucleotide 23 (523 mg, 0.67 mmol) were 
azeotropically dried 3 times by co-evaporating with acetonitrile before dissolving in 3.3 ml of 
acetonitrile. DCI (dicyano imidazole) (266 mg, 2.3 mmol) was subsequently added and the 
reaction mixture was left to stir until the reaction had gone to completion according to TLC. 
200 l of water was added and the reaction mixture was stirred for a minute longer before 
adding 7.2 ml of 0.2M I2 in a mixture of THF/:pyridine 4:1. After 5 minutes the reaction 
mixture was diluted with 25 ml of ethyl acetate and 5 ml of THF and washed with a saturated 
solution of Na2S2O4 
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General procedure for oligonucleotide synthesis 
Oligonucleotides were synthesised using an Applied Biosystems 392 DNA/RNA synthesizer. 
A preprogrammed synthesis was used. The unmodified nucleotides were bought from Link 
technologies or Glen research. The reagents used for the synthesis were an activator 
(sublimed 1H-tetrazole in anhydrous acetonitrile), oxidizing solution (0.10 M I2 in 
THF/pyridine/acetic anhydride), capping mix A (THF/pyridine/acetic anhydride), capping 
mix B (10% 1-methylimidazole in THF/pyridine) and deblocking mix (3% trichloro acetic 
acid in DCM). The coupling efficiency was determined by measuring the conductivity 
generated by the release of the DMT-cation. The nucleotide was released from solid support 
either by removing the solid support from the column reactor or leaving it in there and 
treating it with an ammonium hydroxide solution. In the first case (removing the nucleotide 
on solid support from the reactor) the beads were placed in a flask before adding ammonium 
hydroxide solution and heating at 55 °C for 16 hours. Before purification via HPLC (eluent 
methanol, 0.15 M TEAA pH =7) the freed nucleotide was filtered over a syringe filter.  
In the latter case a 3.5 M solution of ammonia in methanol was added to the reactor. After a 
couple of hours the solution was removed before adding ammonia hydroxide and heating at 
55 °C for 15 hours. After this time the solution was removed and the solid support in the 
reactor was wash with ethanol and water. The protecting groups were removed by FPLC (fast 
protein liquid chromatography), using water as the eluent. 
Ion exchange resin (Dowex 50W) was used to improve mass spectroscopy results.  
General procedure for the copper catalysed 1,3-cycloaddition 
A 0.07 M solution of compound 35 (10 ml, 0.7 mmol) in dioxane was placed in a Schlenk. 
The alkyne containing compound (149 mg, 0.56 mmol) was dissolved in THF (10 ml) and 
added to compound 35. Degassed water (6 ml) was added before adding sodium ascorbate 
(90.8 mg, 0.46 mmol) and copper sulphate hydrate (39.9 mg). The reaction mixture was 
stirred for 20 hours. The organic layer was removed under reduced pressure. The reaction 
mixture was extracted with diethyl ether (3 x 20 ml). The solvent was removed and the crude 
product was purified via flash chromatography over silica. Eluent DCM: acetone 1:1. The 
product was obtained as a white solid. 
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Compound 46a 
Yield 40% (0.22 mmol). 
1
H NMR (400 MHz, CDCl3): δH = 1.11 (9H, s), 1.53-1.66 (12H, m), 1.90 
(3H, bs), 2.03 (2H, s), 2.31-2.35 (2H, m), 3.87 (2H- m), 4.03-4.05 (1H, 
m,), 5.26-5.30 (1H, m), 5.85-5.91 (2H, m) 6.25 (1H, t 
3
J = 7.3 Hz), 7.61 (1H, s) 
13
C NMR (100.6 MHz, CDCl3): δC = 13.2, 27.0, 28.5, 33.0, 36.6, 37.5, 38.8, 42.4, 48.6, 62.5, 
65.1,74.2, 85.3, 86.2, 110.5, 135.3, 150.4, 162.6, 171.6, 177.7 
31
P NMR (121 MHz, CDCl3) ôP = 15.8 (b) 
HRMS (ESI) calcd for C27H31O5N5P (M-BH3 +H]
+
 536.2057 found 536.2045 
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Chapter 3: Non-covalent approach 
3.1 Introduction 
One of the advantages of using the non-covalent approach to introduce a transition metal 
moiety into the chiral surroundings of DNA, is that naturally occurring DNA can be used. 
This means that cheaper sources of DNA can be used such as Salmon testes instead of 
synthesising the strands. Roelfes and Feringa
1
 demonstrated this when they used Salmon 
testes as DNA source along with an intercalating ligand and a copper species to catalyse 
varies reaction types which include aldol condensations, Michael additions and Friedel Craft 
reactions. The obtained enantiomeric excesses were exceptional; however because the 
intercalators randomly interact with DNA strands the exact catalytic environment is 
unknown. Furthermore, because a molar excess of catalyst was used in regards to the amount 
of Salomon testes DNA used, multiple catalytic sites are present. This makes rational 
optimisation very difficult. To gain more insight into DNAzyme catalysis, restrict the number 
of catalytic sites present and know where the catalytic species is located within the double 
helix we opted to use minor groove binders containing a moiety capable of coordinating to a 
transition metal, which interacts with helical DNA in a sequence specific manner.  
The low molecular-weight compounds that function as minor groove binders (MGBs) are 
often based on natural products. Distamycin A (Figure 1), an antibiotic agent, is one of the 
most intensively studied natural minor groove binders. The key structural component of 
distamycin A is a pyrrole based polyamide with an amidino moiety at the terminus. This 
framework allows it to bind to the minor groove via hydrogen bonds (Figure 2) and van der 
Waals and electrostatic interactions.
2
 
 
Figure 1: Natural MGBs Distamycin and Netropsin 
MGBs can effect gene expression and thus they can potentially be used for the treatment of 
diseases.
3
 They can also play an important role in further understanding the mechanistic 
properties of  DNA.
4
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One turn in B-DNA takes approximately 10 base pairs. Although DNA consists of just 4 
building blocks 1,048,576 combinations are achievable for one turn.
5
 It is therefore 
understandable that a lot of work has been put into finding MGBs that target a specific 
sequence.
6
  
Natural MGBs distamycin A and netropsin bind to sequences within the DNA double helix 
that contain 4 or 5 successive A,T base pairs. Through NMR and crystal structure studies it 
was discovered how the specific binding occurs. The minor groove is completely filled with 
the pyrrole rings and a bifurcated hydrogen bond is formed between the amide hydrogen of 
the N-methyl pyrrolecarboxamide and the N3 of adenine and the O2 of thymine (Figure 2). 
The N-methylpyrrole amide does not form hydrogen bonds with G,C base pairs, presumably 
because the hydrogen on the pyrrole is located too deep within the minor groove to allow 
room for binding to the NH2 of guanine.
7
  
 
Figure 2: Distamcycin A binding to AATT 
Therefore polyamide chains containing pyrroles (Py), as in distamycin A, can specifically 
target A,T base pairs in DNA. When a 2:1 ratio of distamycin A to DNA is used the 
distamcyin A aligns itself side-by-side in an antiparallel fashion within the minor groove of 
DNA.
4
  
By adding imidazoles (Im) to the polyamide sequence G-C base pairs can be targeted. The 
imidazole facilitates base-specific recognition via the formation of hydrogen bonds between 
the nitrogens in the ring and the amino groups of guanosine.
8
 The MGBs align themselves 
side-by-side across the minor groove in an antiparallel fashion within the double helix of 
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DNA.
8
 PyPy pairs show a preference for A,T base pairs but cannot distinguish between A,T 
or T,A whereas a pairing of ImPy targets G,C while PyIm targets C,G.
6
 ImIm base pairs 
favour the mismatched pair T,G.
9
 3-Hydroxy-1H-pyrrole (Hp) is a minor groove binder 
which favours A-T base pairs over T-A, however, introducing Hp into the sequence lowers 
the binding affinity, the capability of the polyamide to hold the helical DNA together.
4
 These 
specific recognition characteristics have led to a single-letter code for each MGB pair. This 
code denotes the specific sequence which will be targeted so that PyPy is written as W 
(indicating either A or T), PyIm as C, ImPy as G. The polyamides are often depicted with 
symbols; for example a filled circle represents Im and an open circle Py (Figure 3). The tail is 
generally formed by a  -alanine group, represented in Figure 3 by a diamond, and 
dimethylaminopropyl, represented as a half circle with a plus.  
 
Figure 3:  Representation of a polyamide binding to a DNA strand 
This specific recognition does not indicate how strong the affinity is of individual polyamide 
sequences to their cognate DNA sequence. For example ImHpPyPy-turn-ImHpPyPy binds 
160-fold better to GATC than ImPyPyPy-turn-ImHpHpPy binds to its cognate target even 
though they both contain 1 Im, 2 Py and 1 Hp.
4
 
To allow the polyamide chain to fold back onto its self a turn is often incorporated in the 
scaffold creating a hairpin structure. Studies have shown that the ideal length of the turn unit 
is three methylene blocks. This led to the use of γ-aminobutyric acid as the turn.10 The 
optimum number of pyrrole or imidazole rings in the sequence (before the turn) is five; 
shorter or longer sequences show a decrease in both affinity and specificity. This decrease is 
caused by mismatching between the curvature of the polyamide and the groove of DNA.
8
  
By adding substituents to the butyric acid moiety, the turn functionality, the affinity to a 
DNA sequence could be enhanced. By adding an extra amino group as in the case of (R)-2,4-
diaminobutyric acid a15-fold increase in binding affinity was observed. On the other hand 
(S)-2,4-diaminobutryic acid showed a decrease in binding affinity which is rationalised by 
the steric clash of the amine with the wall of the minor groove. The turn in the hairpin also 
exhibits a specific recognition preference.  It was found that the turn favours T and A 
containing base pairs over those that contain C and G.  There have been reports that state the 
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turn can show improved selectivity when an α-hydroxy is present on the γ-aminobutyric acid 
or when α-diaminobutyric acid is used. Utilising these substances can increase the ability to 
target specific sequences however the overall binding strength, the capability to hold the two 
strands of the helical DNA  together, is lowered.
10
  
Table 1: Melting temperatures of DNA/polyamide complexes
10
 
Polyamide Tm Tm 
- 45.1 (± 0.1) - 
 
54.3 (± 0.3) 9.2 
 
59.8 (± 0.3) 14.7 
 
60.0 (± 0.2) 14.9 
 
59.8 (± 0.2) 14.7 
 
54.9 (±0.1) 10.1 
 
55.1 (± 0.2) 10.0 
 
53.4 (± 0.2) 8.3 
 
50.9 (± 0.2) 5.8 
 
53.0 (± 7.9) 7.9 
      DNA = 50-CTATGGTA GAC-30 
By exchanging 2,4-diaminobutyric acid for 3,4-diaminobutyric acid an improved binding 
affinity was observed for A,T-rich sequences. It was also found that the tolerance for 
synthetic modification of the amine was enhanced. It was postulated that this stability was 
caused by the more central location of the 3,4-diaminobutyric moiety of the turn, on the floor 
of the minor groove. 
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In Table 1 the relative melting temperatures of DNA duplexes in the presence of polyamides 
containing a variety of turns are depicted. It was assumed that relative melting temperatures 
correlate to the binding affinities, the larger the relative melting temperature the higher the 
binding affinities. This was confirmed by analysing several DNA/polyamide complexes via 
footprinting.
10
 
From a synthetic point of view and for comparison with the natural MGBs the C-terminus, 
also known as the tail, is charged. This tail typically consists of a β-alanine connected via an 
amide to a dimethylaminopropyl (Dp) group. The tail also shows some specificity to A,T 
base pairs.
8
 In early studies of the binding of distamycin A it was discovered that the tail was 
always directed to the 5’ end of the adenosine sequence and is thus referred to as 5’ 
directional binding. The binding of ImPyPy-Dp to both WCWGW and to WGWCW was also 
tested. Surprisingly it was discovered that the polyamide would bind to WGWCW but not to 
WCWGW which would only require a rotation of the polyamide. This suggests that there is a 
strong energetic preference for orientation.
8
 
In this chapter we will discuss the synthesis of the polyamides as minor groove binders 
(Figure 4) along with the synthesis of the ligands that will bind to the transition metal. 
Complex studies of the ligand metal complexes and catalysis results will be discussed in 
Chapter 4. 
 
Figure 4: Schematic representation of our non-covalent approach 
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3.2 Results and discussion 
3.2.1 Synthesis of minor groove binders 
The choice of the polyamide sequence is very important as it dictates how strong the binding 
affinity is. Dervan et al.
11
 published an article which contained a list of binding affinities for 
several polyamides and this list was used to choose a suitable polyamide. Polyamide 
ImPyPyIm-turn-PyImPyPy--Dp, has an association constant with the double strand 
oligonucleotide 5’-ATGACGT-3’ of 1×1010 M-1. This polyamide contains a 2,4-
diaminobutryic acid derivate whereas in our case we used a 3,4-deriviative (Figure 5). As 
explained in the introduction this should have a beneficial effect on the binding affinity.  
 
Figure 5: Structure of polyamide ImPyPyIm-(R)NH2-PyImPyPy--Dp (48) 
The polyamide was synthesised on solid support using a PAM resin containing a β-alanine 
moiety (Figure 6) and a number of building blocks (Scheme 1). PAM-resin is a PEG based 
resin which has become popular in solid-phase peptide synthesis because of its tolerance to 
trifluoroacetic acid (TFA). 
 
Figure 6: PAM-resin containing a Boc-β-alanine moiety 
Dervan et al.
12
 noticed that the coupling of an activated imidazole amine with Boc-Py-OBt 
ester did not proceed with a high yield. In order to obtain a higher yield of the polyamide they 
prepared Boc-PyIm dimer unit 51 (Scheme 1). This dimer unit can be prepared on a large 
scale and subsequently be used as a building block during the synthesis of polyamides. 
The butyric acid derivate contains two amines that have different protecting groups thus 
requiring different conditions for deprotection. The different deprotection conditions ensure 
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that the amines can be deprotected individually and prevent the formation of side chains. The 
carboxylic acid on the pyrrole building blocks had been activated via 1-hydroxybenzotriazole 
hydrate (HOBt). The Im-Py-dimer was activated just before use with (benzotriazol-1-
yloxy)tripyrrolidin phosphonium hexafluorophosphate (PyBOP) and diisopropylethyl amine 
(DIEA). After the final coupling the carboxybenzyl (Cbz) group on the turn is removed using 
a strong acid, s mixture of TFA and triflic acid, and purified via HPLC, providing an overall 
yield of 9 %. After lyophilisation the polyamide was ready to couple to a ligand. 
 
Scheme 1: Synthesis of polyamide GWCG 
3.2.2 Ligand synthesis 
To circumvent the problem of oxidation associated with phosphine ligands, we also aimed to 
modify the polyamide with diene-ligands. 
We decided to use a 7-norbornadiene (nbd) derivative containing a carboxylic acid 
functionality which was first reported by Klumpp et al..
13
 Bicyclo[2.21]hepta-2,5-diene-7-
carboxylic acid (53) (Scheme 2) is formed by converting chloro-nbd 52 into a radical using 
lithium p,p’-di-t-butylbiphenyl (LiDBB) and subsequently quenching it with carbon dioxide.  
 
Scheme 2: Synthesis of NBD diene 53 
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In 1976 Zimmerman et al.
14
 reported the synthesis of diene 57 (Scheme 3). The synthesis 
encompasses two successive Diels-Alder reactions followed by a photoinduced 
aromatisation. Diene 57 was obtained as a solid which was difficult to purify. An added 
difficulty was that the compound was unstable. As a solid it was relatively stable especially 
when kept cool however when placed in solution it had the tendency to undergo a retro Diels-
Alder generating benzene and maleic anhydride. 
 
Scheme 3: Synthesis of diene 57 
The chiral diene which Jäschke et al.
15
 used was also synthesised. This diene (63, Scheme 4) 
had a [2.2.2] structure and could be obtained in five steps starting from the cheap and 
commercially available carvone (58). In the first step a good leaving group was introduced 
into the carvone frame work by reacting carvone with N-bromosuccinimide (NBS). The 
leaving group was needed to facilitate the intramolecular alkylation reaction to form 60. After 
the alkylation, the formed diastereomers could easily be separated via flash chromatograph 
on silica gel. In step 3 N-Phenyl-bis(trifluoromethanesulfonimide) (PhNTf2) was used as 
triflating agent. It was imperative that it was dried before use as the water content present in 
the compound when purchased was high enough to quench the lithium diisopropylamide 
(LDA). Once the triflated product 61 was obtained a Suzuki coupling was performed with the 
assistance of a microwave. The final step of this synthesis was a simple hydrolysis using a 
strong base. 
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Scheme 4: Synthesis of chiral diene 63 
3.2.3 Combining minor groove binders with ligands 
 
Figure 7:  Polyamides that were attempted to synthesise 
Once the polyamide and ligand had been synthesised they were ready to be coupled to each 
other. The carboxylic acid groups of 53, 63, and 64 (Figure 7) were activated using a mixture 
of PyBOP and DIEA before coupling to the polyamide. During the activation of compound 
53 the solution turned a deep purple colour.  
The reaction mixtures of the turn modified polyamides were analysed with analytical HPLC 
to check if the reactions had gone to completion. These turn modified polyamides were 
subsequently purified via HPLC. The isolated yields of the dienes were low; a mere 20 %. 
This can probably be improved by adjusting the HPLC conditions. The analytical HPLC 
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traces of the unmodified polyamide and purified compound 65 are shown in Figure 8. The 
shift in retention time is clearly evident (7.5 min. shifts to 9 min). 
 
Figure 8: Left: the HPLC trace of unmodified polyamide 48 Right: the HPLC trace of purified compound 65 
The synthesis of compound 68 was followed by analytical HPLC (Figure 9). By comparing 
the two HPLC traces it was concluded that the starting polyamide was completely converted 
(no peak at 7.3 min. in the right trace). The peak at 5.6 min (right trace) was the OBt group 
from the PyBOP. The other two peaks correspond to the oxidised (10.3 min.) and unoxidised 
(12.5 min.) phosphine polyamide 68. 
13
P-NMR of this crude reaction mixture showed no 
evidence of the phosphine oxide indicating that the oxidation occurred during the running of 
the HPLC sample. To avoid oxidation during purification other methods need to be explored. 
One option is precipitating the polyamide out of solution by adding diethyl ether to a 
concentrated volume of the reaction mixture. 
 
Figure 9: Left:HPLC trace of the unmodified polyamide Right: HPLC trace of the reaction mixture at the end of the 
synthesis of compound 45 
Problems arose with coupling diene 57 to the polyamide. Initially it was attempted to convert 
the anhydride into diacid 69 (Scheme 5). There are various methods known for the formation 
of a diacid from an anhydride, probably the most common being heating. This was not 
attempted as it would likely facilitate the retro Diels-Alder. Acid and base assisted
16
 ring 
opening reactions are also known. Sodium hydroxide was dissolved in water and added to a 
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solution of diene 57 in THF. This gave a biphasic system. After separating the layers the 
aqueous layer was acidified and lyophilised. Degradation of the product occurred somewhere 
between the acidification and lyophilisation. This method should work but due to the small 
amount of 57 that was acquired and its instability no further attempts were made and no effort 
was put into looking into what went wrong.  
 
Scheme 5: Schematic representation of the coupling of diene 6 with the unmodified polyamide 
It is important that the introduced ligands do not have a detrimental effect on the binding 
between the polyamide and the DNA double helix. To assess the influence these 
modifications have on the binding affinity the melting temperature (Tm) of polyamide 65 
(Figure 10) complexed with its DNA target sequence was measured. As a standard polyamide 
71 was also synthesised and its Tm measured. The results are shown in Table 2. The 
introduction of the diene did not have a negative impact on the binding constant, in fact it 
appears to have a stabilising effect on the helical DNA. 
 
Figure 10: Polyamides where the melting temperature was required 
Table 2:  Melting temperature 
 
Tm (
o
C ) TM 
DNA 55.39 ± 0.46 -- 
DNA + 71 67.13 ± 0.31 11.74 ± 0.56 
DNA + 65 68.63 ± 0.22 13.24 ± 0.51 
  Tm-buffer: 10mM sodium cacodylate, 10mM KCl, 10mM MgCl2, 5mM CaCl2 pH 7 
  DNA  = 5'-CGATGGTCAAGC-3' 
Because the Tm’s are not determined under anaerobic conditions the Tm of polyamide 68 
could not be measured.   
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3.3 Conclusion 
The synthesis and subsequent coupling of diene 57 to a polyamide was cumbersome so this 
approach was quickly discarded. 
Dienes 53 and 63 were coupled to the polyamide using standard amide coupling procedures 
resulting in polyamides 65 and 67. The melting temperatures of these polyamides were also 
measured and the results indicated that the dienes have a positive effect on the binding 
affinity of the polyamide DNA complex. 
The Tm of the DNA complex of 68 was not measured as oxidation of the phosphine would 
occur which could potentially result in an enhancing the Tm. NMR indicted that oxidation 
had occurred during HPLC. This means other purification methods should be tried. 
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3.4 Experimental 
General Procedures 
All air- and water-sensitive reactions were carried out under argon utilising standard schlenk 
techniques. Chemicals were purchased from Sigma Aldrich, Acros, Link Technologies, 
Fisher Scientific, Strem and used as is unless otherwise stated. Diisopropylethylamine was 
distilled from CaH2, CDCl3 was distilled from CaCl2 and stored under argon over K2CO3. 
THF and diethyl ether were distilled from sodium/benzophenone. All the distilled solvents 
were stored under argon or nitrogen. Dry DMF was purchased and transferred into a youngs 
ampule. Organic solvents were degassed by three freeze/thaw cycles. Aqueous solutions were 
degassed by bubbling argon or nitrogen through for several hours.   
Thin Layer Chromatography (TLC) was performed using silica plates (polygram 0.3 mm 
silica gel with fluorescent indicator UV254 on aluminium plates) purchased from Merck. 
Compounds on TLC were visualised by UV-detection unless otherwise stated. Flash 
chromatography or purification on a chromatotronTM were performed using the indicated 
eluent. The silica used for flash chromatography was silica gel 60 mesh 70-230 and was 
purchased from Fluka.  
NMR spectra were recorded at room temperature on a Bruker Avance NMR spectrometer 
(300,400 or 500 MHz) or a Varian NMR Spectrometer (300, 400 or 600 MHz). NMR spectra 
recorded at 37 
o
C were measured on a Varian NMR Spectrometer (400 MHz). Chemical 
shifts () are given in ppm. Shifts are relative to a TMS reference (1H or 13C) or an 85% 
H3PO4 reference (
31
P). 
13
C and 
31
P spectra were measured with 
1
H decoupling unless 
otherwise stated.  
MALDI-TOF mass spectra were recorded on a 4800 Plus MALDI TOF/TOF
TM
 Analyzer 
using α-cyano-4-hydroxycinnamic acid as a matrix. 
Tm measurements were recorded on a Cary 100 spectrophotometer equipped with a thermo-
controlled cell holder. The cell path length was 1 cm. 
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Bicyclo[2.2.1]hepta-2,5-diene-7-carboxylic acid (53) 
Compound 53 was synthesised in accordance with the literature procedure.
13
 
A white solid was obtained in yield 40 % (40 mg. 0.3 mmol). 
1
H NMR (CDCl3, 300 MHz) δH = 3.14 (1H, t, J = 1.7 Hz), 3.85 (2H, sextet, J = 1.9 Hz), 
6.75 (4H, dt J = 5.9 and 4.0 Hz) 
13
C NMR (DMSO d6, 75 MHz) δC = 51.5, 85.4, 141.4, 143.3, 171.5 
(4R,4aR,6aS,7S)-4,4a,7,7a-tetrahydro-4,7-ethenocyclobuta[f]isobenzofuran-
1,3(3aH,6aH)-dione (54)  
Compound 54 was synthesised in accordance with the literature procedure.
13
 
A yellowish solid was obtained in 85 % yield (1.7 g, 8.4 mmol). 
1
H NMR (CDCl3, 400 MHz) δH = 2.74 (2H, s), 3.00 (2H, s), 3.17 (2H, bs), 5.84 (2H, s), 
5.96-5.98 (2H, m) 
13
C NMR (CDCl3, 100 MHz) δC = 36.8, 43.3, 43.9, 129.0, 138.1, 172.5 
2,5-dimethyl-3,4-diphenylcyclopenta-2,4-dienone (55)  
Compound 55 was synthesised in accordance with the literature procedure.
13
 
A yellowish solid was obtained in 83 % yield (5.1 g, 10.0 mmol). 
1
H NMR (CDCl3, 400 MHz) δH = 0.49 (3H, s), 1.17 (3H, s).1.57 (3H, s), 2.23 (3H, s) 6.56-
7.2 (20H, m)
 
13
C NMR (CDCl3, 100 MHz) δC = 25.9, 28.6, 30.0, 149.3, 150.6, 153.8  
exo-4,7-Diniethy1-5,6-diphenylpentacyclo8[.2.2.14,7.0'.y.0".L]-entadeca-
5,13-d~en-15-onedicarboxylAiccid Anhydride (56)  
Compound 56 was synthesised in accordance with the literature procedure.
14
 
A brownish solid was obtained in 93 % yield (818mg, 1.8 mmol). 
1
H NMR (CDCl3, 400 MHz) δH = 1.13 (6H,s), 1.94-2.00 (4H, m), 2.97 (2H, s), 3.27 (2H, 
bs), 6.42 (2H, t, J = Hz), 6.85-6.89 (4H, m), 7.07-7.16 (6H, m) 
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Bicyclo[2.2.2]octa-2,5-diene-7,8-dicarboxylic Anhydride (57) 
Compound 57 was synthesised in accordance with the literature procedure.
13
 
The compound was not obtained in pure form. 
1
H NMR (CDCl3, 400 MHz) δH = 3.12 (2H, s), 4.17 (2H, s), 6.44-6.46 (4H, m) 
(5R)-5- [ (2.9-1 -Bromo-2-methoxypropan-2-y1] -2-methylcy clohex- 
2-enone (59)  
Compound 59 was synthesised in accordance with the literature procedure.
17
 
Compound 59 was obtained as an oil in 85 % yield (7.4 g, 28 mmol). 
1
H NMR (CDCl3, 300 MHz) δH = 1.26 (3 H, s, tert-CH3,). 1.78(3 H, s, CH3), 2.1-2.65 (5 H, 
m), 3.24 (3 H, s, OCH3), 3.45 (2 H,  CH2Br), 6.7 (1 H, br s, olefin) 
(lS,4S,SR)-Methoxy-l ,8-dimethylbicyclo-[2.2.2]oct-5-en-2-one (60A)  
Compound 60A was synthesised in accordance with the literature procedure.
17
 
Compound 60A was obtained as an oil in 64 % yield (1.2 g, 6.6 mmol). 
Characterisation agreed with the literature.
17
 
Trifluoro-methanesulfonic acid 8-methoxy-1,8-dimethyl-bicyclo[2.2.2]octa-2,5-
dien-2-yl ester (61)  
Compound 61 was synthesised in accordance with the literature procedure.
18
 
Compound 61 was obtained as an oil in 33 % yield (110 mg, 0.35 mmol). 
1
H NMR (CDCl3, 300 MHz) δH = 1.26 (3H, s, Me), 1.28 (1H, d, J  = 12.1 Hz, CH2), 1.46 
(3H, s, Me), 1.78 (1H, d, J  = 12.1 Hz, CH2), 3.16 (3H, s, OMe), 3.59 (1H, dt, J = 6.5, 
6.5Hz),.14-6.08 (2H, m,),6.31 (1H, t, J  = 13.2 Hz) 
(1S,4R,8R)-ethyl4-(8-methoxy-1,8-dimethylbicyclo[2.2.2]octa-2,5-dien-2-
yl)benzoate (62)  
Compound 62 was synthesised according to the literature procedure.
15
 The 
product was obtained as yellow oil. Yield 68 % (154 mg, 0.49 mmol). 
1H NMR (300 MHz, CDCl3): δH = 1.33-138 (7H, m);, 1.39 (3H, t, J = 7.1 Hz), 1.63 (1H, d, 
J = 12.3 Hz), 3.25 (3H, s), 3.70 (1H, dt, J = 1.2 Hz, 6.1 Hz), 4.41 (2H, q, J = 67.1 Hz), 6.19 
(1H, dd, J = 1.3 Hz, 7.2 Hz), 6.26 (1H, d, J = 5.9 Hz), 6.42 (1H, t, J = 6.7 Hz), 7.22-7.26 (2H, 
m), 7.98-8.02 (2H, m) 
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13C NMR (75 MHz, CDCl): δC = 14.4, 21.97 24.8, 45.4, 47.8, 50.0, 50.6, 60.9, 84.2, 128.4, 
128.6, 129.0, 132.8, 134.1, 141.5, 144.5, 149.2, 166.7 
(1S,4R,8R)-4-(8-methoxy-1,8-dimethylbicyclo[2.2.2]octa-2,5-dien-2-
yl)benzoic acid (63)  
Compound 63 was synthesised according to the literature procedure.
15
 
 The product was obtained as a white solid. Yield 92 % (39.1mg, 0.14 mmol). 
1
H NMR (300 MHz, DMSO-d): δH = 1.22 (3H, s), 1.27 (1H, d, J = 11.9 Hz), 1.29 (3H, s), 
1.57 (1H, d, J = 11.9 Hz), 3.10 (3H, s), 3.68 (1H, td, J = 6.2 Hz, 1.3 Hz), 6.15 (1H, dd, J = 
7.3 Hz, 1.4 Hz), 6.17 (1H, d, J = 6.0 Hz), 6.39 (1H, t, J=6.9 Hz), 7.21 (2H, m), 7.88 (2H, m), 
12.84 (1H, s) 
13
C NMR (75 MHz, DMSO-d6,): δC = 21.3, 24.5, 44.6, 46.8, 49.3, 50.4, 83.3, 128.0, 128.7, 
128.8, 132.9, 133.9, 141.0, 143.8, 148.1, 167.1 
Polyamide 48 
Polyamide was synthesised in accordance with literature protocols.
10
 The 
resin which was used for the synthesis was a pre-loaded Boc--Ala PAM resin (0.81 
mequiv/g). Neat 3-dimethylamino-1-propylamine at 60 
o
C for 16 h was used to cleave the 
polyamide form the resin. Products were purified by preparative reverse-phase HPLC and 
characterised by analytical HPLC, UV–visible spectroscopy, and MALDI-TOF mass 
spectrometry. 
UV (H2O) max at 318 nm 
MALDI-TOF-ms:  1239 m/z 
Polyamide 65 
The coupling of diene 53 with the polyamide proceeded via the coupling 
protocols used for polyamide synthesis. Purified via preparative reverse-
phase HPLC.  
UV(H2O) max at 318 nm 
MALDI TOF-ms: 1358 (expected mass 1356) 
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Polyamide 67 
The coupling of diene 53 with the polyamide proceeded via 
the coupling protocols used for polyamide synthesis. Purified 
via preparative reverse-phase HPLC.  
UV(H2O) max at 318 nm 
MALDI TOF-ms: 1504 (expected mass 1504) 
Polyamide 68 
The coupling of diphenyl phosphine benzoic acid with the 
polyamide proceeded via the coupling protocols used for 
polyamide synthesis. Attempts were made to purify via precipitating the polyamide out of 
solution and by washing. Neither method had the desired out come as only the oxidised 
compound was obtained. 
UV max at 318 nm 
MALDI TOF-ms: 1542 (expected mass 1526, expected mass if oxidised 1542)  
31
P-NMR (162 MHz, unlock): -5.78   
Melting temperature 
2 nmol of each single strand oligonucleotide was placed in quartz cuvette (1 ml) before 
adding 690 l degassed Tm buffer (Tm-buffer: 10 mM sodium cacodylate, 10 mM KCl, 10 
mM MgCl2, 5 mM, CaCl2  pH 7) and 310 µl of the desired degassed dioxane/water mixture. 
The cuvette was placed in the spectrophotometer. Before commencing with the measurement 
the samples were heated to 90 °C and cooled to a starting temperature of 25 °C. The 
measurement was carried out by heating the samples from 25 to 90 °C at a rate of 5 °C/min 
while the UV absorption was recorded at λ = 260 nm. The measurement was repeated before 
2.2 nmol of polyamide was added and the samples were remeasured twice. 
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Chapter 4: Catalysis 
4.1 Introduction 
Chapter 1 highlighted the need for catalysis. In the past water was often neglected as a 
suitable solvent because of the low water-solubility of organic substrates and the water-
sensitivity of some reagents and reactive species.
1
 However there are some clear benefits of 
using water as the solvent. Water is an abundant naturally occurring solvent which makes it 
inexpensive. Furthermore water is a non-flammable and environmentally safe solvent with no 
toxicity. In addition water has some unique properties. For example compared to most 
organic solvents it has a high dielectric constant, a high heat capacity and high cohesive 
energy density (550 cal/ml (2302740 kJ/m
3
)). These characteristics give rise to the so called 
hydrophobic effects, clustering of compounds with nonpolar regions in water to reduce the 
hydrocarbon-water interfacial area, which plays an essential role in the formation of micelles 
and the folding of biological molecules such as proteins and assists with molecular 
recognition.
1-2
 By utilising these properties enzymes have been able to conduct highly 
efficient and selective reactions under mild conditions.
3
  
In 1980 Rideout and Breslow
2
 reported that the hydrophobic interactions also play a role in 
catalytic reactions with small hydrophobic molecules in water. They reported that the Diels 
Alder reaction of cyclopentadiene and butenone (Figure 1) was 100 fold faster when carried 
out in water than in 2,2,4-trimethylpentane. In methanol the speed of the reaction was found 
to be in between these two extremes. Ions present in the water will also have an effect on the 
hydrophobic effect because they change the way that water interacts with nonpolar 
molecules.
4
 Since Rideout and Breslow’s discovery a range of other reactions have been 
carried out in water,
5
 these include Friedel-Crafts rearrangements,
6
 Aldol reactions,
7
 Michael 
additions
7
 and [3,3]-Sigmatropic Rearrangement.
8
 
 
Figure 1: The Diels-Alder reaction of cyclopentadiene and butenone 
The bases present in helical DNA form a hydrophobic cleft (Figure 2) which we plan to 
exploit. By introducing a catalyst into this cleft and by performing the catalytic reactions in 
an aqueous system we plan to make full use of the hydrophobic effects.  
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The rest of this chapter will focus on three types of water-compatible asymmetric catalytic 
reactions, these are: 
1) Allylic amination 
2) 1,4 Cycloaddition 
3) Hydroformylation 
 
 
 
Figure 2: Left: Crystal structure of B-DNA (CGC GAA TTC GCG)
9
 represented as a cartoon and seen from above. The arrow 
indicates the hydrophobic cleft. Right: Schematic side view with the square highlighting the location of the hydrophobic 
cleft. 
4.1.1: Allylic substitution 
Transition metal catalysis has proved a useful method for the formation of C-C, C-N and C-O 
bonds, especially allylic substitution reactions facilitate these formations. In allylic 
substitution a leaving group on the allylic position is displaced by a nucleophile so that the 
resulting product still contains a double bond allowing further functionalisation (Scheme 1). 
Although various metals have been employed in these reactions, Pd complexes have received 
the most attention.
10
 An allyl can coordinate to a metal centre in three different ways (Figure 
3); the manner in which it does this and its dynamic behaviour, influence the stereogenic 
outcome of reactions which proceed through these allyl intermediates.
11
 
 
Figure 3:  Different ways an allyl can coordinate to a transition metal 
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Assigning names to these complexes follow the standard Cahn-Ingold-Prelog rules which 
means that R and S terminology can be used to describe the stereochemistry.
11
 The syn and 
anti-positions in a planar allyl complex are depicted in Figure 4. 
 
Figure 4:  Syn and anti definition in a planar allyl complex 
In the -allyl intermediate there are three possible geometries which can be adopted: syn-syn, 
syn-anti or anti-anti (Figure 5). Linear olefins in the E-configuration form complexes which 
prefer the syn-syn geometry while cyclic substrates are required to adopt the anti-anti 
geometry.
12
 
 
Figure 5: The possible geometries of the -allyl palladium complex 
4.1.1.1 Palladium catalysed allylic substitution 
In 1965 Tsuji et al.
13
 were the first to report a palladium assisted allylic substitution reaction 
using a stoichiometric amount of palladium. About a decade later Trost et al.
14
 reported the 
first catalytic version of this reaction using palladium complexes with phosphines as ligands 
which they patented as the first catalytic allylic alkylation.
15
 This palladium catalysed 
allylation of a nucleophile (Scheme 1) has since been named after its discoverers and is 
known as the Tsuji-Trost reaction.
16
 The reaction has increased in scope covering not only 
alkylation (C-C bond formation) but also amination (C-N bond formation) and C-O bond 
formation and has become a benchmark reaction for testing the efficiency of new chiral 
ligands.
17
 It is generally accepted that the catalytic cycle proceeds as depicted in Scheme 2. 
 
Scheme 1: The Tsuji-Trost reaction 
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The substitution occurs via a SN2 type reaction. This does not mean that it is similar to the 
uncatalysed SN2 reactions. In the catalysed version of a SN2 reaction the metal moiety 
displaces the leaving group to form an 3-allyl complex.18  
 
Scheme 2: Catalytic cycle of palladium catalysed nucleophilic allylic substitution of soft (left) and hard (right) 
nucleophiles  
The catalytic cycle begins with Pd
0
 complex 72 which often is generated in situ from a Pd
II
 
source such as [Pd((3-allyl)Cl]2. Complex 72 activates the allylic compound containing a 
leaving group such as an acetate group forming stable cationic (3-allyl) PdII intermediate 74 
by oxidative addition.
19
 After this step the catalytic cycle can follow one of two routes 
depending on the nucleophile used. In the case of a soft nucleophile (left cycle in Scheme 2) 
the attack on the allyl fragment occurs outside the coordination sphere of the metal. In this 
complex the allyl group is formally an anion but can undergo nucleophilic attack owing to the 
high electrophilicity of palladium to form the allyl product. The product is bound to the Pd
0
 
complex via a 2-Pdalkene bond before it is released liberating complex 72 to partake in the 
cycle once again.
12a, 19
 
Hard nucleophiles, whose conjugate acids have a pKa > 25, have a slightly different catalytic 
cycle (right cycle in Scheme 2).
12
 Instead of attacking the allyl group directly they attack the 
metal centre and the product is formed by reductive elimination.
20
 Soft nucleophiles are more 
commonly used in allylic substitution reactions. 
For a reaction to give 100 % enantiomeric excess (ee) and conversion, one step must be able 
to differentiate between the enantiotopic groups or faces. Each step in the cycle provides an 
opportunity for enantioselection to take place, with the exception of the decomplexation 
step.
12
 There are five potential sources where enantioselection can occur (Figure 6): a) metal-
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olefin complexation, b) departure of the leaving group c) enantiofacial discrimination of the 
-allyl complex d) nucleophilic attack at the enantiotopic termini and e) enantiofacial 
discrimination in the nucleophile.
12
 
 
Figure 6 : Potential sources of enantiomeric-discrimination in allylic substitution 
As with other asymmetric reactions the ability to differentiate between the enantiotopic faces 
of the olefin is a possible mechanism of enantio selection. The ligand-metal complex must 
distinguish between the two prochiral faces of an unsymmetrically substituted olefin. 
Although it is generally considered that the complexation of an olefin with palladium is rapid 
and reversible the stability of the d
10
 metal-olefin complex varies widely. Examples where 
enantioselective olefin complexation is the enantiodetermining step are limited. A 
combination of factors are required for this to be the enantiodetermining step,
12a
 these include 
faster ionisation of one enantiomer of the olefin over the other and a slow -- equilibration 
relative to the nucleophilic capture of the diastereomer (Figure 6, a).
12a, 19
 
If there are two potential leaving groups on a meso or achiral disubstituted system then 
enantiotopic ionisation (Figure 6, b) is the enantiodetermining step. When ionisation of a 
racemic chiral allylic system leads to a meso--allyl intermediate then the enantiodetermining 
step is determined by differentiation of the enantiotopic allyl termini (Figure 6, c). Two 
diastereomeric palladium complexes can form when the initial olefin coordination is fast and 
reversible (equilibration through a -- rotation). In this case the product is formed from 
either the most abundant or more reactive diastereomer (Figure 6, d). Lastly a prochiral 
nucleophile can determine the enantioselectivity by enantiofacial discrimination of an achiral 
allyl complex (Figure 6, e).
12
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Allylic amination, the Tsuji-Trost reaction with an amine as nucleophile, generates allyl 
amines which are fundamental building blocks in organic chemistry and therefore synthetic 
methods to prepare them are very important.
21
 Because the amines are usually sufficiently 
basic themselves, no additive needs to be added, which is required with alkylation, to 
facilitate the reaction. The reaction is compatible with aqueous environments
22
 which makes 
it an interesting reaction for our nucleotide based catalysis. 
Other metals than palladium have been shown to catalyse allylic substitution reactions often 
showing different regioselectivities than palladium. Generally but not always, palladium 
forms linear products out of terminal allylic electrophiles whereas complexes composed of 
other metals tend to favour the branched products.
23
 Iridium is one such metal.  
4.1.1.2 Iridium diene catalysts in allylic substitution 
It has been well established that phosphorous donor compounds are efficient ligands in 
asymmetric catalysis. However they have the potential to oxidise making them inactive. 
There are other compounds available that are effective ligands in catalysis which do not have 
this drawback.
24
 Since 1827 when Zeise’s salt (K[PtCl3(C2H4)]), one of the first 
organometallic compounds, was discovered, numerous metalalkene complexes have been 
synthesised. Olefins are labile ligands which can easily be replaced with ligands which 
exhibit a stronger binding affinity such as phosphines and nitrogen and this makes them 
useful as precatalysts. It is therefore understandable that using chiral dienes as ligands in 
catalysis has received little attention. Hayashi et al.
25
 and Carreira et al.
26
 changed this by 
independently demonstrating that chiral dienes can be used in asymmetric catalysis.
27
 
It is fair to say that the majority of the attention that iridium catalysed allylic substitution has 
received in recent years has focused on the use of [Ir(COD)Cl]2 complexes with 
phosphoramidites as ligands.
18
 Since it was first developed in 1997 by Takeuchi
28
 iridium 
catalysed allylic substitution has rapidly developed and slowly our understanding of the 
mechanism has developed (Scheme 3).
18
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v 
Scheme 3: Mechanism for phosphoramidite-iridium catalysed catalysis
23a
 
In the absence of a phosphorus ligand, iridium complexes are still active. By employing 
chiral dienes high ee’s (over 98 %) can even be obtained.18, 26 It should be noted however that 
the enantiodetermining step differs from that of reactions utilising complexes containing a 
phosphorous moiety. When a racemic starting compound is used and the reaction is allowed 
to run until complete conversion is obtained then the product is racemic. However impressive 
enantiomeric excesses are obtained when the reaction is stopped after 50 % conversion. 
When the remaining starting material is analysed enantiomeric enrichment is observed in the 
same ratio as the product.
26
 It is assumed that steric hindrance plays a crucial role in the 
observed selectivity (Figure 7).  
 
Figure 7: Proposed explanation for the selectivity of the diene-iridium catalysed  allylic substitution
26
 
4.1.2: 1,4 Cycloaddition 
Hayashi et al.
25
 developed a catalytic 1,4-cycloaddition (Scheme 4) employing dienes as 
ligands around the same time as Carreira was using dienes with iridium.  
 
Scheme 4: 1,4 cycloaddition using boronic acids 
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The mechanism that Hayashi proposed
25
 is depicted in Scheme 5. Active catalyst 81 is 
formed by reacting the rhodium precatalyst with sodium tetraphenylborate after which the 
complex undergoes transmetalation to give rise to triphenylborane and species 82. With the 
aid of the Lewis acidic triphenylborane the enone can subsequently insert itself into the 
phenyl-rhodium bond generating species 83. This is followed by protonolysis which produces 
the product along with an alkoxyrhodium intermediate (84). Finally the active species is 
regenerated by ligand exchange with sodium tetraphenylborate. 
 
Scheme 5: Proposed mechanism for the rhodium catalysed 1,4 cycloaddition with sodium tetraphenylborate 
4.1.3 Hydroformylation 
Hydroformylation also known as oxo synthesis (Scheme 6), is one of the most important 
reactions in industry that uses homogeneous catalysts
29
 and has an annual production of 6 
million metric tons.
30
 During the reaction an alkene is converted into an aldehyde using 
syngas (synthesis gas: a 1 to 1 mixture of hydrogen and carbon oxide) making the atom 
economy of the reaction 100%. 
 
Scheme 6: General hydroformylation reaction  
The reaction was first discovered in 1938 by Roelen
29
 and is a versatile method to 
functionalise alkenes and create enantiomerically pure aldehydes.
31
 The original catalyst was 
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a cobalt species, HCo(CO)4, but nowadays the most commonly used catalyst motif for these 
reactions is based on diphosphines chelating to a rhodium species.
31b
  
In 1993 Takaya et al.
31a
 played a significant role in the breakthrough in the field of 
asymmetric hydroformylation (AHF) with their chiral phosphinephosphite ligand, (R,S)-
BINAPHOS  ((R)-(2-(diphenylphosphino)-1,1’-binaphtalen-2’-yl)-((S)-1,1’-binaphtalen-2,2’-
yl)phosphite) (Figure 8). Since then other chiral ligands have been developed containing two 
different phosphorus moieties. 
 
Figure 8: (R,S)-BINAPHOS 
4.1.3.1 Hydroformylation in water 
In order in minimise the environmental impact water based reactions have been receiving 
much attention. Besides the fact that water is cheap, non-flammable and non-toxic it allows 
for easier recycling of the catalyst.
32
 Two important industrial applications which employ this 
concept are the Wacker process (since the late 50’s early 60’s) and the Ruhrchemie Rhône-
Poulenc process (since 1984).
30
  
The Wacker process was used for the manufacturing of acetaldehyde from ethylene (Scheme 
7). At the time acetaldehyde was an important industrial intermediate and with a production 
exceeding 2 million tons per year it sparked a lot of attention. Today this acetaldehyde is less 
important as the intermediates used in industry can be manufactured using different 
methods.
33
 
 
Scheme 7: Hydroformylation of A) ethylene (wacker process) B) propene (Ruhrchemie Rhône-Poulenc process)  
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In the Ruhrchemie Rhône-Poulenc process propene is converted into n-butanal using rhodium 
tppts (3,3′,3′′-Phosphinidynetris(benzenesulfonic acid) trisodium) as a catalyst precursor.34  
In 1968 Wilkinson and co-workers
35
 proposed the widely accepted mechanism for the 
triphenylphosphine (TPP) rhodium system. A common starting position in this cycle is 
RhH(TPP)3CO. The first step in the catalytic cycle begins with the formation of a trigonal-
bipyramidal hydrido rhodium complex (Scheme 8). Under 1 bar of CO pressure this complex 
can form three species. One species contains three TPP groups while the other two contain 
two. The suggested next step involves the dissociation of carbon monooxide in the case of 
85b and 85c and TPP for 85a giving square planar species 86. The vacant site is substituted 
by an alkene to generate 87. A hydride migration can then occur to give either an n- or i-
alkyl. CO coordination takes place followed by migratory insertion to give 89. Species 90, 
which releases the aldehyde, is formed by reacting 89 with dihydrogen.
35-36
 
 
Scheme 8: Dissociative mechanism of Hydroformylation 
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4.2 Results and discussion 
In organic solvents the double helix form, which nucleic acids can adopt, have a tendency to 
dissociate giving two single strands. To take full advantage of using nucleotides the chiral 
environment of the double helix needs to remain intact. The extent of dissociation in organic 
solvent is dependent on several factors. These factors include the organic solvent which was 
utilised as well as on the sequence of the nucleic acid. Dioxane is a solvent which is often 
used as a co-solvent in the aqueous reactions we are looking into.  
Melting temperature graphs can be used to find out at what temperature more than half the 
double helix of oligonucleotides has dissociated. That is why the melting temperature of 
double helix 5’-CCA TGACGA AGA-3’ was determined in different concentrations of 
dioxane (Graph 1). The pyrrole/imidazole minor groove binders tend to increase the 
temperature of dissociation, because extra hydrogen bonds can be formed to hold the helix 
together. Polyamide 71 (Chapter 3, Figure 10) was added to the oligonucleotide solutions 
containing different concentrations of dioxane in order to determine at what temperature and 
concentration most of the oligonucleotides are found as single stands.  
Graph 1:  The melting temperature of DNA in different concentrations of dioxane. 
 
Each reaction was carried out in 690 ml Tm buffer (Tm-buffer: 10 mM sodium cacodylate, 10 mM KCl, 10 mM MgCl2, 5 mM, CaCl2  pH 7), 
310 µl dioxane/water mixture and 2 nmol DNA. After running the Tm’s with the DNA only 2.2 nmol polyamide was added.  
The decrease in integrity of the double helix in elevated concentrations of dioxane is clearly 
visible (the downward slope in Graph 1). The integrity decreases more quickly, although it 
remains higher, when polyamides are used. That is why at 30 °C and 40 % dioxane the two 
virtually merge.  Because the graph indicates when more than half the nucleotides have 
dissociated it is advisable to remain above the line when choosing reaction conditions. That is 
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why it was decided not to go above 30 % dioxane when reactions are to be done at room 
temperature. 
4.2.1 Allylic substitution 
4.2.1.1 Diene-Ir catalysis 
The purpose of synthesising the dienes described in Chapter 3, was to use them as ligands in 
allylic substitution reactions with Ir. 3-Acetoxy-3-phenylprop-1-en-1-ylium (A) was chosen 
as substrate with morpholine (B) as nucleophile (Scheme 9). Unlike palladium, which favours 
nucleophilic attack at the least hindered position resulting in linear product D, iridium favours 
the more hindered option to form the chiral branched product C. 
 
Scheme 9: allylic substitution reaction for iridium catalysis 
Several dienes containing a suitable linker for coupling to polyamide 48 (Chapter 3, Figure 5) 
were prepared. Ligands 53 and 57 in Figure 9, were chosen because they are achiral which 
would increase the likelihood that the chirality seen in the product was caused by the 
oligonucleotides. Diene 53 was put on hold when it was discovered that it was unlikely to 
form a stable complex with iridium (see later in this chapter). Diene 57 turned out to be very 
unstable and coupling to the polyamide was unsuccessful. Therefore dienes 62/63 were also 
studied.  
 
Figure 9: Dienes with a [2.2.2] motif that have been investigated 
Carreira et al.
26
 observed that after mixing norbornadiene (nbd) with [IrCl(COE)2]2 (COE = 
cyclooctene) for 4 days only by-products were formed. However Osborn et al.
37
 reported that 
nbd displaces the COE in [IrCl(COE)2]2 to form a microcrystalline compound with an 
unconfirmed structure. They claim that the structure is unlikely to be monomeric. This 
compound is not readily soluble nevertheless it can be converted into other iridium 
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complexes (Figure 11). To avoid the formation of a microcrystalline compound we theorised 
that this compound was a polymer and that having a bulky substituent on the bridge would 
prevent the formation of this species. Therefore, we studied complex formation between 
chloro-nbd 93 (Figure 10) and iridium(I).  
 
Figure 10:  Chloro-nbd 93 
After stirring chloro-nbd 93 and [IrCl(COE)2]2 for 24 hours at room temperature no complex 
formation was visible in the 
1
H-NMR spectrum. Therefore it was decided to heat the mixture 
overnight at 37 
o
C. 
1
H-NMR showed the formation of a new species (Figure 12). When the 
reaction mixture was concentrated and subsequently redissolved the iridium complex 
decomposed. On the other hand when the complex remained in solution it was stable for 
several weeks. 
 
Figure 11: Possible iridium complexes formed from the iridium-nbd microcrystalline complex  
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 Figure 12: NMR of the formation of chloro-nbd Ir complex 
To establish if the NMR data corresponded to the desired complex the chemical shifts of the 
olefin were compared to the calculated chemical shifts using computational methods (Table 
1). The validity of this method was tested by comparing the measured chemicals shifts of 
[IrCl(COD)]2 (COD = cyclooctadiene) to those computational predicted using the B3LYP 
function as specified in GAUSSIAN 09 (Table 2). 
Table 1: Measured and calculated chemical shifts of COD and Ir-(nbd-Cl) complex 
Proton nbd-Cl 
Experimental Calculated 
Ir-(nbd-Cl) complex 
Experimental Calculated 
Diene  6.7, 6.6 7.2 (Cl, anti) 
7.0 (Cl, syn) 
4.1, 4.0 3.4 (Cl, anti) 
3.8 (Cl, syn) 
CH 3.6 3.6 3.8 3.6 
CH-Cl  4.1 4.3 3.4 3.8 
1
http://www.sigmaaldrich.com/spectra/fnmr/FNMR004153.PDF 
2
Grobbelaar,  E. et al. Inorganica Chimica Acta 2006 
359 3800 
* 
Calculated by  Dr. Jevgenij A. Raskatov. All computations were performed using the B3LYP function as 
specified in GAUSSIAN 09. Optimisations were performed using the combined basis set BS1 (SDD+ECP augmented by an f 
polarisation function (z = 0.938) on Ir, 6-311G(d) otherwise), NMR chemical shifts were calculated with the larger basis 
set BS2 (SDD+ECP augmented by an f polarisation function (z = 0.938) on Ir, 6-311+G(d,p) otherwise). TMS (0.0 relative 
ppm) was used for reference. 
 
 
Chapter 4: Catalysis 
93 
Table 2: Measured and calculated chemical shifts of COD and [IrCl(COD)]2 
Proton COD
1
 
Experimental   Calculated 
[IrCl(COD)]2
2
 
Experimental    Calculated 
Diene 5.6 6.0 4.2 3.4 
CH2 2.3 2.5 2.2, 1.6 2.4 (endo) 1.9 
(exo) 
1
http://www.sigmaaldrich.com/spectra/fnmr/FNMR004153.PDF 
2
Grobbelaar, E. et al. Inorganica Chimica Acta 2006 359 
3800 
* 
Calculated by Dr. Jevgenij A. Raskatov. All computations were performed using the B3LYP function as specified in 
GAUSSIAN 09. Optimisations were performed using the combined basis set BS1 (SDD+ECP augmented by an f 
polarisation function (z = 0.938) on Ir, 6-311G(d) otherwise), NMR chemical shifts were calculated with the larger basis 
set BS2 (SDD+ECP augmented by an f polarisation function (z = 0.938) on Ir, 6-311+G(d,p) otherwise). TMS (0.0 relative 
ppm) was used for reference. 
It is clear that the chemical shifts correspond closely to those predicted by the calculations 
(Table 2). This is also true for the free ligand 93. For the complexation of iridium with COD 
the calculated value is slightly off for the olefin protons but the trend is clear. The same trend 
is visible with the nbd complex and therefore, it can be assumed that the desired complex has 
been formed. 
The complex was formed in an aprotic solvent (CDCl3) but the catalytic reaction will take 
place in a protic solvent. To test the stability of the complex deuterated methanol was added 
to the solution containing the metal complex. After 1 hour degradation products were clearly 
visible and after two days there were only trace amounts of complex left (Figure 13). Because 
the complex proved to be unstable under protic conditions dienes with a [2.2.2] structure 
were also investigated.  
 
Figure 13: NMR spectra of chloro-nbd Ir complex after addition of a protic solvent 
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The [2.2.2] structure of dienes 62/63 has been tried and tested in the allylic amination 
reactions
22
 so no problems were expected. The scale on which the catalytic reactions were to 
be carried out on was very small, 50 l, and therefore, test reactions were carried out to 
compare the outcome with the experiments done on a larger scale (1 ml). The following 
complexes were used to do this:  
1) [Ir(COD)Cl]2 (formed from [Ir(COE)2Cl]2 and COD)) 
2) [Ir(COE)2Cl]2  
3) [Ir(COE)2Cl]2 with diene 62 
The test reactions were carried out in dichloromethane (DCM). When the reaction was 
carried out on the 1 ml scale only the [Ir(COD)Cl]2 reactions showed conversion. This was 
surprising as  Jäschke et al.
22
 reported the [Ir(COE)2Cl]2 complex was active as well as diene 
92 as ligand. On the small scale the DCM evaporated overnight. The reaction was repeated in 
an aqueous medium with dioxane as a co-solvent. [Ir(COD)Cl]2 was used as the catalyst 
because it was the only active complex.  The reactions were left for 4 days and in the case of 
the small scale reaction the internal standard, substrate and product had evaporated to varying 
degrees. On the large scale this was not detected therefore it is advisable that the reactions are 
carried out on a larger scale than 50l. 
To find out why the catalytic reaction with diene 62 showed no conversion NMR experiments 
were conducted. Upon mixing diene 62 with [Ir(COE)2Cl]2 in CDCl3 no complexation could 
be detected even when the complex was heated for 48 hours at 37 °C. It is known that 
[Ir(COE)2Cl]2 forms complexes with dienes slowly,
22, 26
 which is why a more reactive Ir 
precatalyst was tried: [Ir(C2H4)2Cl]2. Unfortunately no complexation was seen using this 
precatalyst either, not even upon heating to 40 °C for 48 h. It is possible that higher 
temperatures are needed. 
4.2.1.2 Phosphine-Pd catalysis 
Because palladium favours the least hindered position in allylic substitution a different 
substrate, 1,3-diphenylallylacetate (E), was chosen (Scheme 10). 
 
Scheme 10: Allylic substitution with palladium 
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Nucleosides modified with a phosphorous have been tested in catalysis in the past.
38
 In all 
likelihood if the monomer is not catalytically active, then a longer strand will also be 
inactive. Therefore monomer 46a (Figure 14) was deprotected using methanol and after the 
removal of BH3 protecting group and evaporation of the solvent ligand 46b was used in 
allylic amination (Scheme 10). Both diastereomers of 25a were also tested in this reaction 
because it is known that phosphoramidite also perform well in substitution reactions. 
 
Figure 14: Ligands tested in palladium catalysed allylic substitution 
The results are shown in Table 3. The reactions were carried out in DCM. It was also tested 
to see if adding K2CO3 as a base would have any effect on the reaction, this turned out not to 
be the case. Ligand 46b was the only ligand that gave any conversion. The ee could not be 
determined by HPLC because there was an impurity present in the reaction mixture after 
filtration which was UV active and overlapped with the peak of one of the enantiomers. 
Table 3: Conversions of the allylic substitution reactions with palladium 
Ligand K2CO3 Conversion (100 %) 
-- -- 0 % 
--  0 % 
46a -- 100 % 
46a  100 % 
25a diastereomer 1 -- 0 % 
25a diastereomer 1  0 % 
25a diastereomer 2 -- 0 % 
25a diastereomer 2  0 % 
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4.2.2 1,4-Cycloaddition 
The 1,4-cycloaddition which Hayashi reported was done in only 10 % water and 90 % 
dioxane (Scheme 11). From the melting temperature graph (Graph 1) it is clear that when the 
co-solvent is dioxane a minimum of 70 % water is required to avoid dissociation. For this 
reason the cycloaddition was tested with different water concentrations. Above 60 % water 
no conversion was measurable. This does not mean that the reaction does not proceed with 
higher concentrations of water as a precipitate was observed which could indicate that the 
complex was precipitating out of solution. Therefore a water soluble diene should be 
synthesised to further test the limitations of this reaction. 
 
Scheme 11: The 1,4-cycloaddition 
4.2.3 Hydroformylation 
Aqueous biphasic systems for rhodium catalysed hydroformylation are of interest in industry 
as they allow for quantitative recycling of the catalyst. As of yet the industrial viability has 
only been proven in the case of lower olefins (under four carbon atoms). In the case of higher 
olefins problems occur due to their low solubility in the aqueous phase. 
39
 Because of this 
lower solubility we opted to use a single phase system using a co-solvent to transfer the 
substrate into the aqueous layer. Styrene is often used as a bench mark substrate for 
hydroformylation so it was decided to use this substrate (Scheme 12). 
 
Scheme 12: Hydroformylation of styrene 
To determine the best co-solvent test reactions were carried out with tppts as ligand. The 
results are shown in Table 4 
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Table 4: Conversion of styrene in an aqueous co-solvent system 
Entry co-solvent  5% 
Conversion  (b:1) 
10 % 
Conversion (b:1) 
20 % 
Conversion (b:1) 
1 DMF 26 % (9:1) 43 % (11:1) 90 % (16:1) 
2
a) 
DMF 90 % (18:1) Full conversion 
(20:1) 
-- 
3 MeOH 32 % (10:1) 35 % (8:1) 53 % (12:1) 
4 Dioxane 21 % (10:1) 39 % (9:1) 77 % (9:1) 
5
a) 
Dioxane Full conversion 
(20:1) 
Full conversion 
(21:1) 
-- 
Reaction conditions: Rh(acac)CO = 0.33 mol, tppts = 3.05 mol, styrene = 0.1 mmol, temperature =30°C, 24 hours, buffer B (20 mM 
MOPS, 48 mM NaCl) in water), total V = 1.0 ml pressure = 50 bar a)pressure = 80 bar 
Out of the three solvents which were investigated, methanol (Table 4, entry 3), gave the 
lowest overall conversions. The better performing co-solvents (DMF (dimethylformamide) 
and dioxane) were also tested at a higher pressure (entry 2 and 5). By increasing the pressure 
full conversion could be obtained. The ratio between the branched and linear products also 
increased. In the future reactions will be carried out with the higher pressure (80 bars) with 
dioxane as co-solvent. The three ligands tested in allylic amination reaction were also used as 
ligands in the hydroformylation of styrene. Compound 46b was used in this test reaction to 
determine if it would be worthwhile to carry the reaction out using longer strands of 
oligonucleotides containing this triazole motif. Phosphoramidites 25a were also tried because 
the use of phosphoramidites in catalytic reactions has been growing in popularity.
40
 Their 
potential hydrolysis sensitivity prevents the reactions being performed in aqueous media 
therefore chloroform was chosen as the solvent. The results are shown in Table 5. 
Table 5: Conversion and enantioselectivity in hydroformylation of styrene 
Entry Ligand Conversion (%) ee (%) 
1 -- 100 0 
2 46b 0 - 
3 25a diastereomer 1 15 8 % enantiomer 2 
4 25a diastereomer 2 27 18 % enantiomer 1 
Reaction conditions: Rh(acac)CO = 1.0 mol, ligand = 5.1mol, styrene = 1.2 mmol, diphenyl ether = 0.5 mmol, 1.0 ml chloroform, 
pressure 40 bars, 18 hours,  40 °C 
When ligand 46b was added to the rhodium pre-catalyst the solution instantly turned yellow 
which was taken as an indication that the ligand had coordinated to the rhodium. This was 
also evident from the lack of conversion (Table 5, entry 2). If no or partial complexation had 
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occurred then the results would have mimicked that of Rh(acac)CO (Table 5, entry 1), in 
other words there would have been product formation. Because no product formation had 
occurred it indicated that an inactive rhodium species was formed. Until more data are 
obtained explaining the reason why no conversion was observed it is not recommended 
attempt is reaction using the more costly (both financially and time consuming) longer 
nucleotides.  
No colour change was noticed when the phosphoramidites were added to the rhodium 
complex however the phosphoramidites did form an active complex with rhodium as 
conversions were detected, and more importantly, enantiomeric excess was observed. Ojima 
et al.
40
 also used monodentate phosphoramidites in the hydroformylation. As substrate they 
opted for the more volatile and thus for us incompatible, substrate allyl cyanide. Several 
members of our group noticed that on the scale we do our reactions volatile 
substrates/products are lost when purging the autoclave. The catalyst system of Ojima et al. 
gave high conversions (often 100 %) and enhanced enantioselectivities. They found that 
ligand/metal ratio had little effect on the reaction. Therefore it is unlikely that changing the 
ligand metal ratio in our system will improve the conversion but using a different substrate or 
solvent might prove to be more promising.  
4.3 Conclusion 
There are only a few examples known were iridium complexes have a nbd derivate as a 
ligand
37, 41
 and these complexes generally have a phosphine as a co-ligand. We wished to 
synthesise an iridium nbd complex without adding a phosphine. To achieve this a nbd-
derivative with a bulky group on the bridge was coordinated to an iridium COE complex. The 
formation proceeded smoothly but the complex had stability issues, although it remained 
stable in solution in an aprotic solvent for up to two weeks decomposition occurred when the 
sample was concentrated or when a protic solvent was added. It was therefore decided that 
ligand 53 was not very suitable for iridium DNA assisted catalysis. Stable nbd complexes 
with rhodium are known so changing the transition metal to rhodium and the reaction to, for 
example, the 1,4-cycloaddition, could be a possibility. Initial steps were undertaken to 
determine if the 1,4-cycloadditon was an option by increasing the water content compared to 
the reported reaction conditions. When the water content reached above 60 % no product 
formation was observed and a precipitate was formed, possibly indicating that the metal 
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complex had precipitated from solution. A more water soluble metal complex is needed to 
further test the limits of this reaction. 
Dienes with a [2.2.2] structure are known to coordinate to [Ir(COE)2Cl]2 but unfortunately 
attempts to coordinate diene 62 were unsuccessful, even when the more reactive precatalyst 
[Ir(C2H4)Cl]2 was used and the complex was subjected to an elevated temperature of 40 °C. 
This result is surprising as ligands very similar to diene 92 which has been used with both 
precatalysts in allylic substitution. 
Double stranded oligonucleotides have the tendency to lose their double helix three 
dimensional structure and become two single strands in the presence of organic solvents. 
Dioxane has been used as a co-solvent in water containing reactions which we were 
interested in. Therefore it was a good co-solvent to start with. To determine at which 
concentration dioxane significantly alters the composition of the oligonucleotides Tm 
experiments were done. Using this method it was discovered that the concentration of 
dioxane should not exceed 30 % otherwise the majority of the oligonucleotides will be 
present in their single strand form. This means that the chiral environment created by the 
double helix will be lost. 
Because oligonucleotides are expensive and synthetic oligonucleotides are obtained on mol 
scale test reactions were carried out to determine the effect of the reaction volume on the 
reaction rate for allylic substitution. The initial reactions were carried out in DCM using 
[Ir(COD)Cl]2 as catalyst, on two different scales 1.0 ml and 50 l. Reproducible results were 
only obtained with the large volumes. On the small scale, even in closed eppendorfs, the 
solvent evaporated. To reduce the amount of evaporation the solvent was changed to water 
containing MgClO4 and Na(ClO4)2 with dioxane as a co-solvent. After the desired length of 
time the results were analysed by GC. Unfortunately the amount of substrate and therefore 
product was too small to be extracted and measured reliably. Lager volumes are thus needed 
although 1.0 ml might be too large. 
High pressures are required for hydroformylation when water is used as a solvent and 
improved the ratio between linear and branched product. Of the three co-solvents that were 
investigated methanol gave the worst results. The difference between dioxane and DMF was 
small and because Tm measurements of oligonucleotide-polyamide complexes in different 
concentrations of dioxane had be measured it was decided to proceed with dioxane. 
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Ligands 46b, 25a diastereomer 1 and 25a diastereomer 2 were tested in the allylic 
amination of 1,3-diphenylallyl acetate with benzylamine and the hydroformylation of styrene 
with some interesting results. Both of these reactions were carried out in organic solvents. In 
allylic amination only ligand 46b showed full conversation after 12 hours while the other two 
showed no conversion. The addition of the K2CO3 had no effect on the conversion giving the 
same results as the reactions carried out without the addition of this extra base. The fact that 
46b gave full conversion within a mere 12 hours is promising as the same ligand motif will 
be present when strands of oligonucleotides are tried. 
In hydroformylation the opposite was observed, 46b gave no conversion while 25a 
diastereomer 1 and 25a diastereomer 2 showed some reactivity.  Rh(acac)CO showed the 
highest reactivity giving full conversion within the 18 hour timeframe; naturally the product 
was racemic. Although the enantiomeric excesses obtained with 25a diastereomer 1 and 25a 
diastereomer 2 were low, 8 % and 18 % respectively, they did show that the chirality of the 
nucleotide has an effect on the enantiodetermining step giving opposite selectivities. It is also 
interesting to note that the reaction speed of these enantiomers also differs. Although these 
results are fascinating, this type of ligand should not be introduced into a oligonucleotide 
because phosphoramidites are water sensitive and hydrolysis of the ligand will occur. 
Oligonucleotides with a triazole motif like ligand 46b are not recommended to be used in 
hydroformylation because the smaller more accessible ligand showed no conversion and the 
longer oligonucleotides are not expected to improve reaction rates but enhance the 
enantiomeric excess.   
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4.4 Experimental 
General Procedures 
All air and water sensitive reactions were carried out under argon utilising standard Schlenk 
techniques. Chemicals were purchased from Sigma Aldrich, Acros, Link Technologies, 
Fisher Scientific, Strem and used as is unless otherwise stated. CHCl3 and CDCl3were 
distilled from CaCl2 and stored over K2CO3 under argon. Dioxane and hexanes were distilled 
over sodium. MeOH was distilled from I2/CaH2. All the distilled solvents were stored under 
argon or nitrogen. Dry DMF was purchased and transferred into a youngs ampoule. 
Degassing of organic solvents was done by three freeze/thaw cycles. Aqueous solutions were 
degassed by bubbling argon or nitrogen through for several hours.   
Thin Layer Chromatography (TLC) was performed using silica plates (polygram 0.3 mm 
silica gel with fluorescent indicator UV254 on aluminium plates) purchased from Merck. 
Compounds on TLC were visualised by UV-detection unless otherwise stated. Flash 
chromatography or purification on a chromatotron
TM
 were performed using the indicated 
eluent. The silica used for flash chromatography was silica gel 60 mesh 70-230 and was 
purchased from Fluka.  
NMR spectra were recorded at room temperature on a Bruker Advance NMR spectrometer 
(300,400 or 500 MHz) or a Varian NMR Spectrometer (300, 400 or 600 MHz). NMR spectra 
recorded at 37 
o
C were measured on a Varian NMR Spectrometer (400 MHz). Chemical 
shifts () are given in ppm. Shifts are relative to a TMS reference (1H or 13C) or an 85% 
H3PO4 reference (
31
P). 
13
C and 
31
P spectra were measured with 
1
H decoupling unless 
otherwise stated.  
Tm measurements were recorded on a Cary 100 spectrophotometer equipped with a thermo-
controlled cell holder. The cell path length was 1 cm. 
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Melting temperature 
2 nmol of each single oligonucleotide strand was placed in a quartz cuvette (1 ml) before 
adding 690 l degassed Tm buffer (Tm-buffer: 10 mM sodium cacodylate, 10 mM KCl, 10 
mM MgCl2, 5 mM, CaCl2  pH 7) and 310 µl of the desired degassed dioxane/water mixture. 
The cuvette was placed in the spectrophotometer. Before commencing with the measurement 
the samples were heated to 90 °C and cooled to a starting temperature of 25 °C. After which 
the samples were heated from 25 to 90 °C at a rate of 5 °C/min while the UV absorption was 
recorded at λ = 260 nm. The measurement was repeated before 2.2 nmol of polyamide was 
added and the samples were remeasured twice. 
Chlorobis(ethylene)iridium dimer [Ir(CH2=CH2)2Cl]2 
500 mg of chlorobis(cyclooctene)iridium dimer was dissolved in 5 ml hexane.  The reaction 
mixture was cooled to -40 °C before vigorously stirring while bubbling ethylene gas though 
the reaction mixture for 1 hour. The yellow brownish colour changed to grey. The suspension 
was allowed to settle before cooling to -70 °C and washing 3x with 5 ml of hexane under 
ethylene pressure. The residue was placed under vacuum to dry. Upon placing under argon 
the solid turned dark red. 
The complex is stable up to three months if kept at -20 °C under argon. 
Iridium complex with dienes 
Chlorobis(cyclooctene)iridium dimer or chlorobis(ethylene)iridium dimer was dissolved in 
deuterated chloroform. A 
1
H NMR spectrum was taken before adding an excess of diene. The 
reaction mixture was warmed to 37 °C and an NMR was taken at set intervals 
 The complex with 7-chlorobicylco [2.2.1] hepta-2,5-diene was stable in solution for up to 
two weeks but degrades when concentrated. 
1
H NMR (CDCl3) H = 4.0 (4H, m possible dd 29 Hz, 25 Hz), 3.8 (2H, s), 3.4 (1H, s)  
The complex with diene 62 would not form. 
Degradation of the 7-chlorobicyclo[2.2.1]hepta-2,5-diene iridium complex 
To a solution of the 7-chlorobicyclo[2.2.1]hepta-2,5-diene iridium complex in CDCl3 a 
couple of drops of deuterated methanol were added. After which a 
1
H-NMR was taken at set 
intervals registering the decomposition of the original complex. 
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General procedure for the 1,4-cycloaddition 
[Rh (COE)Cl]2 (1 equv.) and norbornadiene (1.1 equv.) were dissolved in degassed dioxane. 
To this solution cyclohexenone (30 equv.) was added followed by sodium tetraarylborate (45 
equv.) and the desired amount of water. The reaction was stirred for 24 hours at room 
temperature after which the reaction mixture was passed over a silica gel plug and washed 
through with EtOAc. Conversion was determined by TLC. 
General procedure for allylic amination of 1,3-diphenylallyl acetate with benzylamine 
The reactions were carried out in GC vials. In some of the vials 0.03 mmol K2CO3 was 
added. Separate stock-solutions were made of the metal complex [Ir(COE)2Cl]2, 
[Ir(CH2=CH2) or Pd(
3
-C3H5)Cl]2 in either dioxane or dichloromethane and the desired 
amount was placed in a GC vial or eppendorf. To this the appropriate amount and ligand (in 
dioxane or DCM) was added. The reaction mixture was further diluted with distilled water 
(containing Mg(OCl4)2 M, Na2(OCl4) M), or DCM before adding the substrate and internal 
standard (in DCM or dioxane). Finally the nucleophile (in dioxane or DCM) was added.  
Once the reaction had been stirred for the desired length of time a sample was removed to 
determine the conversion by GC before passing the reaction mixture over silica gel to remove 
the metal to determine the ee. 
A RTX column was used and helium was used a carrier gas. The pressure was isocratic at 
100 bar. The temperature was held at 50  °C for 2 minutes before heating to 300 °C at a rate 
of 20 °C/min. This was held for 10 minutes. Retention times: benzylamine: 6.87 min, 
diphenyl ether (internal standard): 8.06 min, 1,3-diphenylallyl acetate (starting material): 
11.79 min, 1,3-diphenylallyl benzylamine (product): 14.49 min. 
The ee was determined with HPLC using a CHIRACEL OD-H column. An isocratic mixture 
of 99.5:0.5 hexane:iso-propanol with a flow rate of 0.5 ml/min was used. An impurity 
overlapped one of the peaks of the enantiomers so ee was not determined.  
General procedure for hydroformylation of styrene 
The hydroformylation experiments were carried out in an autoclave with magnetic stirring. 
The reactions were carried out in 6 ml vials with caps containing septa. Stock solutions were 
made of the Rh(acac)(CO)2 and styrene. After adding the appropriate amounts the vials were 
capped and a needle was place through the septa of each cap. The autoclave was purged with 
argon before the vials were added. The autoclave was purged 3 times with 10 bars of syngas. 
Before it was charged with 40 bars and the temperature was brought to 40 °C. The reaction 
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mixture was stirred for 24 hour after which the autoclave was cooled by placing in an ice bath 
before releasing the pressure. 
Conversion was determined by GC. A RTX column was used and helium was used a carrier 
gas. The pressure was isocratic at 100 bar. The temperature was held at 50 °C for 2 minutes 
before heating to 300 °C at a rate of 20 °C/min. This was held for 10 minutes. Retention 
times were: styrene: 3.60 min, branched product: 5.57 min, linear product: 6.10 min. and 
diphenyl ether (internal standard): 8.07 min. 
The ee was determined by GC. A supelco beta-dex column was used. He was the carrier gas. 
An isocratic temperature was used of 80 °C and100 bar. Retention times were: enantiomer 1: 
10.16 min, enantiomer 2: 10.39 min, linear product 14.12, internal standard diphenyl ether: 
19.32, styrene and solvent peak overlap. 
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List of Abbreviations 
Abbreviation  Name in full 
A   adenine 
AAC   azide alkyne cycloaddition 
Ac   acetyl 
acac   acetylacetone 
Ada   adamantylacetyl 
AHF   asymmetric hydroformylation 
aq.   aqueous 
(R,S)-BINAPHOS (R)-(2-(diphenylphosphino)-1,1’-binaphtalen-2’-yl)-((S)-1,1’-
binaphtalen-2,2’-yl)phosphite 
BINAP  2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
BINOL  1,1'-Binaphthalene-2,2'-diol 
Biot   biotin 
BOC   Di-tert-butyl dicarbonate 
BOP (Benzotriazol-1-yloxy)tris (dimethylamino)phosphonium 
hexafluorophate 
t-Bu   tertiary-butyl 
C   cytosine 
cald   calculated 
CAMP   cyclohexyl (2-methoxyphenyl)(methyl)phosphine 
cat.   catalyst 
Cbz   carboxybenzyl 
CDI   1,1’-carbonyldiimidazole 
COD   cyclooctadiene 
COE   cyclooctene 
Cp
*
   pentamethylcyclopentadienyl 
CPG   controlled pore glass 
CuAAC  copper catalysed azide alkyne cycloaddition 
Cy   cyclohexyl 
d   deoxy 
D   Dalton  
DABCO  1,4-diazabicyclo[2.2.2]octane) 
DBB   4,4’-di-tert-butylbiphenyl 
DCI   4,5-dicyanoimidazole 
DCC   dicyclohexylcarbodiimide 
DCM   dichloromethane 
DIC   1,3-diisopropylcarbodiimide 
DIEA   N,N-diisopropylethylamine 
DMAP   4-(Dimethylamino) pyridine 
DMF   dimethylformamide 
DMT   4,4'-dimethoxytrity 
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DNA   deoxyribonucleic acid 
L-Dopa  L-3,4-dihydroxyphenylalanine 
Dp   dimethylaminopropyl 
dpp   diphenylphosphine 
dppf   1,1′-Bis(diphenylphosphino)ferrocene  
Duphos  (+)-1,2-Bis[(2R,5R)-2,5-diisopropylphospholano]benzene  
EDC   ethyl-(N’,N’-dimethylamino)propylcarbodiimide hydrochloride 
ee   enantiomeric excess 
E-factor  environmental factor 
equv.   equivalent 
ES   enzyme substrate complex 
Et   ethyl 
FPLC   fast protein liquid chromatography 
G   guanine 
GC   gas chromatography 
h.   hour 
HATU O-(7-Azabenzotriazol-1-yl)-N,N,N’,N′-tetramethyluronium 
hexafluorophosphate  
HOBt   1-hydroxy-1H-benzotriazole 
Hp   3-Hydroxy-1H-pyrrole  
HPLC   high pressure liquid chromatography 
Im   imidazole 
L   ligand 
LDA   Lithium diisopropylamide 
lyrs   light years 
M   metal 
MALDI -TOF  Matrix-Assisted Laser Desorption Ionisation Time of Flight 
Me   methyl 
MGB   minor groove binder 
min.   minute 
MOPS   4-morpholinepropanesulfonic acid 
MS   mass spectrometry 
Mw   molecular weight 
nbd   norbornadiene 
NBS   N-bromosuccinimide 
NMR   nuclear magnetic resonance  
PA   polyamide 
PAM   4-hydroxymethyl-phenylacetamidomethyl 
PCR   polymerase chain reactions 
PEG   polyethylene glycol 
Ph   phenyl 
pI   isoelectric point 
POM   chloromethylpivalate 
ppm   parts per million 
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Pr   propyl 
PTFE   polytetrafluoroethylene 
Py   pyrrole 
PyBOP  benzotriazol-1-yloxyl)tripyrrolidin phosphonium hexafluorophosphate 
Q   environmental quotation 
RhAAC  rhodium catalysed azide alkyne cycloaddition 
Rf   retention factor 
RNA   ribonucleic acid 
RP   reverse phase 
rRNA   ribosomal ribonucleic acid 
rt.   room temperature 
SELEX   Systematic Evolution of Ligands by eXponential Enrichment  
syngas   synthesis gas  
T   thymine 
TBTA   tris-(benzyltriazolylmethyl)amine 
TBTU   O-(Benzotriazol-1-yl)-N,N’,N’-tetramethyluronium tetrafluoroborate 
TCA   trichloroacetic acid 
TCEP   tris(2-carboxylethyl)phosphine  
Tf   triflic 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
Tm   melting temperature 
TMGA  N,N,N’,N’-tetramethylguanidinium azide 
TMS   Tetramethylsilane 
TNT   trinitrotoluene 
TOF   turn over frequency 
TPP   triphenylphosphine 
tppts   3,3′,3′′-Phosphinidynetris(benzenesulfonic acid) 
U   uracil 
UV   ultra violet 
v/v    volume/volume 
w/w   weight/weight 
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